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Molecular interactions provide the basis and structure of all life and living 
systems. Specifically, small molecules are principle mediators of essential processes 
across phyla, including signal transduction and metabolism, as well as inter-
organismal chemical attraction and defense. Therefore, the knowledge of the identity 
of these molecules and their biosynthetic and degradation pathways is central to 
understand living systems. In this thesis, a comparative metabolomics approach will 
be discussed which is heavily based on 2D-NMR Spectroscopy but often requires 
LC/MS validation. Using this technique, two main small-molecule metabolic 
pathways have been investigated in the purview of this thesis using the model 
organism C. elegans.  
The first one, the steroid biogenesis pathway, plays a central role in C. elegans 
metabolism by dictating its reproductive and developmental future and even its 
lifespan. Steroidal ligands have been proposed to bind to the Nuclear Hormone 
Receptor – DAF-12 and here using our approach we identify for the first time, the 
complete set of DAF-12 ligands in an unbiased and unambigious way. We then 
continue to investigate the biosynthetic pathway of these ligands and uncover 
components of the network that were previously unrecognized, thus fundamentally 
revising the current viewpoint on this subject for future researchers to explore. 
The second pathway, tryptophan degradation pathway, has increasingly 
become one of the most studied pathways in living organisms. In the context of this 
thesis we first identify anthranilic acids, metabolites of the tryptophan degradation 
pathway, as the fluorophore, that results in a striking blue fluorescence moments prior 
to the worm’s death. This result is astounding since until now the origin of this 
fluorescence was considered to be something entirely different. Our findings 
reconfirm the importance of tryptophan catabolism across all organisms and provide 
us with a fantastic opportunity to explore and elucidate the roles of the non-small 
molecule components of a biosynthetic network, using metabolomics.
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CHAPTER 1 
 
PREFACE 
 
This preface provides an introduction to the key concepts used in the 
subsequent chapters and the reasons behind pursuing these investigations. It 
also contains a brief description of each of the chapters. 
  
C. elegans as a model organism for chemists to understand small 
molecule signaling pathways that regulate key biological processes 
Molecular interactions provide the basis and structure of all life and 
living systems. Specifically, small molecules are principle mediators of 
essential processes across phyla, including signal transduction and 
metabolism, as well as inter-organismal chemical attraction and defense. 
Therefore, the identity of these molecules, their biosynthetic and degradation 
pathways, interaction with other biomolecules (protein, DNA, RNA) and 
associated networks of biotransformation and function, provides a much 
needed, deeper understanding of biological processes. In-depth knowledge 
about these small molecules and the associated networks, however will not 
alone answer higher level questions about life, behavior and disease. 
Molecules and networks are not alive, but the cross-talk between these 
networks and molecules, ultimately leading to a phenotype as a response to a 
change e.g. in the environment create what we perceive as "life", and we 
therefore need to understand small molecule metabolism in the context of 
whole organisms. Since the diversity of living organisms is enormous, it is 
necessary to focus on investigating a small number of simpler, representative 
organisms that are chosen for experimental convenience. A detailed and 
2 
holistic understanding of these organisms, termed as “model organisms” have 
provided, and will continue to provide, answers to key questions in biology, 
and unravel new questions and new directions for scientific research to move 
forward.  
One of the most important model organisms for biomedical research is 
the roundworm, Caenorhabditis elegans, (1) because of its biological 
tractability and (2) because a large number of physiological pathways show 
analogies to similar pathways in higher animals, with intriguing implications for 
human health research. C elegans is a small, transparent, free-living 
nematode, which grows to an adult length of approximately 1.5mm (Riddle et 
al., 1997). It is found in microbe-rich habitats such as decaying plant matter 
(Felix and Branendle, 2010), but can be easily grown on a bacterial lawn of 
Escheria coli in Petri dishes. It is highly differentiated yet small enough for 
high-throughput operations, has a short lifespan, can be easily grown in 
normal laboratory conditions without specialized training, equipment and 
stringent requirements of sterility, and experimentation with it is free of ethical 
concerns. These factors along with the significant additional advantage that C. 
elegans is one of the first organisms whose genomes were sequenced (C. 
elegans Sequencing Consortium, 1998), and can be genetically manipulated 
easily, provides chemists with a tractable platform for speedy verification of 
chemical hypothesis in a simple multicellular animal (Hulme and Whitesides, 
2011). As a result, C. elegans has been extensively used in large-scale 
genetic screens (Sugimoto et al., 2004; Bazopoulao and Tavernarakis, 2009) 
and has had considerable impact on the understanding of neurodegenerative 
diseases (Dimitriadi et al., 2010; Wolozin et al., 2011), metabolic diseases 
(Hashmi et al., 2013) and infectious diseases and immunity (Powell et al., 
2008, Marsh et al., 2012). A fairly recent review (Kaletta and Hengartner, 
3 
2006) provides information about how important C. elegans has become in 
biomedical research, especially in understanding signaling pathways that 
regulate development and aging (Chapter 2 and 3) and neurodegeneration, 
immunity and death (Chapter 4).  
  
4 
Table P.1. C. elegans disease models.  (adapted from Kaletta and 
Hengartner, 2006)  
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Specifically, research efforts aimed at understanding aging have 
focused on one unique feature of nematode development – the dauer 
diapause. In favorable environments, which constitute optimum temperature 
(20-22 °C), high food (E. coli) availability and low local population density, the 
worm rapidly develops from an embryo to adult through four larval stages (L1-
L4) in 3.5 days.  This reproductive development ultimately leads to gravid 
hermaphrodites which reproduce over a 3-d to 5-d period and live for another 
2-3 weeks. However, if exposed to higher temperatures (≥ 24 C), scarcity of 
food and overcrowded conditions, C. elegans will divert development to a 
specialized, alternative larval stage called the – “dauer diapause” (L3d), which 
is non-feeding and can persist under adverse conditions for several months 
(Cassada and Russell, 1975) (Figure P.1). This non-feeding dauer stage (from 
German “dauer” for enduring) is a unique example of developmental plasticity 
where life history traits are linked with changes in the environment. Genetic 
screens for mutants that either cannot attain the dauer stage or form dauer 
larvae constitutively have identified nearly 40 DAF (DAuer Formation) genes 
that are directly involved in dauer stage control (Riddle and Albert, 1997). 
Subsequent studies revealed a significant role for genes of the dauer pathway 
in the general regulation of lifespan, and orthologs of dauer genes in higher 
organisms appear to be involved in aging as well. (Kenyon et al., 1993; Tatar 
et al., 2003; Kenyon et al., 2001) Epistasis analysis of daf genes revealed a 
complex signalling network that regulates dauer diapause entry and exit and is 
connected with conserved pathways including steroid signaling, tryptophan 
degradation and serotonin signalling, cGMP, TGF-β and Insulin/IGF signalling.  
Furthermore, C. elegans genetic and RNAi screens have implicated a large 
number of additional genes with lifespan control (Hansen et al., 2005; 
6 
Hamilton, et al., 2005) many of which are also involved with fat storage 
regulation. (Ashrafi et al., 2003).  
Despite its significance as a model organism and relevance as a 
disease model, the number of small-molecule signals and other metabolites 
that have been discovered from C. elegans is surprisingly, very small 
(Schroeder et. al., 2006). However this is not a reflection of the importance of 
small molecule mediated signaling in C. elegans and other nematodes, 
because the few C. elegans derived compounds identified so far are 
associated with strong phenotypes and are crucial in many physiological 
pathways. Therefore, investigation of small molecule signaling and 
biosynthesis in C. elegans provides a unique and untapped opportunity to 
significantly advance our current understanding of animal biology.  
 
Figure P.1. C. elegans life cycle. Figure adapted from Fielenbach and 
Antebi, 2008. 
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Small-molecule signaling in the Dauer pathway in C. elegans. 
 In 1982, it was demonstrated by Riddle and Golden that then unknown 
small molecules released by C. elegans induce entry into and antagonize 
recovery from the dauer diapause. The subsequent identification of a mutant 
strain, daf-22, deficient of dauer-inducing activity (dauer pheromone) in its 
metabolite extracts, confirmed that this signal must be nematode-derived 
(Golden and Riddle, 1985). But it took more than 20 years after this initial 
discovery to finally reveal the chemical composition of the dauer pheromone. 
Several laboratories contributed to the discovery of the family of ascarosides 
(Figure P.2), hydrophilic glycosides of the di-deoxy sugar ascarylose, as major 
constituents of the dauer pheromone (Butcher et al., 2007; Jeong et al., 2005; 
Pungaliya et al., 2009). It also became clear that the dauer pheromone was 
not a single compound but a complex mixture of ascarosides in which certain 
components act synergistically in dauer induction. 
 
Figure P.2. Ascarosides that have been shown to induce dauer 
formation. Figure adapted from Ludewig and Schroeder, 2012. 
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Following their identification as constituents of the dauer pheromone, it 
was discovered that ascarosides serve additional major signaling functions. 
Srinivasan et. al found that specific concentrations and combinations of 
ascarosides can attract C. elegans sex-specifically (Srinivasan et al., 2012). 
Macosko et al. unraveled the neuronal network that regulates hermaphrodite 
repulsion of ascarosides. More recently research from the Schroeder lab 
showed that indole ascarosides and p-hydroxybenzoyl ascarosides act as 
highly potent aggregation signals that attract both males and hermaphrodites 
(von Reuss et al., 2012), while ascaroside primarily produced by males attract 
hermaphrodites specifically (Izrayelit et al., 2012). The example of ascarosides 
is highly encouraging since the identification of chemical structures 
responsible for dauer induction led to the subsequent identification of more 
small molecules which in turn catalyzed a much broader understanding of 
pheromone mediated nematode behavior, providing an unique example of 
structure- and concentration-dependent differential activity of small molecules. 
More work is currently going on to understand the interaction of these small-
molecules (ascarosides) with other biomolecules (their yet unidentified 
cognate receptors), and one can only imagine the possibilities of the 
information that may be obtained from such studies.  
 But the ascarosides are not the only small molecules that have been 
discovered to play key roles in the C. elegans dauer pathway. Using natural 
pheromone extracts, it has been shown that the dauer pheromone signal is 
detected and integrated by specific chemosensory neurons (Bargmann, 2006). 
When exposed to ascarosides, these neurons either initiate or block the 
production of secondary messengers such as TGF-β, cGMP, serotonin and 
insulin-like peptides. Downstream of these conserved neuroendocrine 
pathways, lies a nuclear hormone receptor, DAF-12 (Figure P.3). 
9 
 
Figure P.3. Signaling network that regulates development, lifespan and 
metabolism in C. elegans. Figure adapted from Ludewig and Schroeder, 
2012. 
 
DAF-12, an ortholog of the human Vitamin-D receptor, represents a 
main switch in the signaling cascade controlling dauer formation and in recent 
years a large number of labs have reported the possible existence of small 
molecule hormone(s) in C. elegans as endogenous ligands for DAF-12 
(Gerisch et al., 2001; Jia et al., 2002, Matyash et al., 2004). These molecules, 
possibly of steroidal origin, constitute the second major group of small 
molecule metabolites detected in C. elegans regulating fundamental 
10 
processes in nematodes, many of which are conserved in higher organisms, 
and determining the identity of these molecules is therefore a necessity. 
 
The nuclear hormone receptor DAF-12 and steroid signaling in C. 
elegans 
Nuclear Hormone Receptors (NHRs) constitute an ancient and probably 
the largest superfamily of ligand-dependent transcription factors, i.e. DNA-
binding regulatory proteins that fine tune transcriptional pathways, in response 
to diverse signals e.g. developmental, environmental and nutritional. They are 
involved in every aspect of development, physiology and disease in humans 
(Sladek et al., 2010) and are highly ubiquitous in and unique to the animal 
kingdom. Because they can be pharmacologically manipulated by agonists or 
antagonists, NHRs represent a key mechanism for disease intervention.  
NHRs share considerable amino acid sequence similarity in two, highly 
conserved domains – the DNA binding domain (DBD) and the ligand binding 
domain (LBD) (Renaud and Moras, 2000). Following ligand binding, an NHR 
undergoes a conformational change in which a C terminal activation helix, AF-
2, folds back onto the LBD core, locking the NHR in an active confirmation, 
thus achieving transcriptional activation (Moras et al., 1998; Bledsoe et al., 
2002; Cronet et al., 2001). NHRs having no ligand or for which no ligand(s) 
has been discovered, are termed orphans (Mangelsdorf et al., 1995) and 
efforts to identify cognate ligands for orphan receptors have contributed 
significantly to a deeper understanding of their physiological roles and 
mechanism. However identification of ligands for orphan receptors has often 
been based on random compound screens or other biased approaches, and in 
many cases it remains unclear if the reported ligands are true endogenous 
ligands. 
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 When the C. elegans genome was completely sequenced (Consortium, 
1998), one of the most surprising features was the enormously large family of 
284 genes encoding for NHRs. It appears almost all of these genes produce 
proteins and are not pseudogenes (Miyabayashi et al., 1999) and therefore the 
C. elegans NHR family is far larger than its human (48 genes), mouse (49 
genes), and fly (18 genes) counterparts (Maglich et al., 2001). This massive 
expansion of NHR genes in C. elegans provides an intriguing opportunity for 
biologists to study evolution and diversification of this family, as well for 
chemists to investigate the identity and biological roles of ligands of these 
NHRs. However, only a few C. elegans NHRs have known functions (Taubert 
et al., 2010). Currently mutation or suppression by RNA interference (RNAi) of 
50 C. elegans NHRs are known to elicit detectable phenotypes (Harris et al., 
2009) and only a few of these have been studied in any real depth.  
DAF-12 is perhaps the most studied and best understood C. elegans 
NHR. As transcription factors that can both activate and repress, NHRs have 
the distinct ability to function as ligand-dependent switches that decide 
between several alternate organismal fates. Accordingly DAF-12 has a key 
role in the choice between the dauer diapause and reproductive development 
(Magner et al., 2008). Cellular and molecular genetic analysis studies suggest 
that environmental and physiological cues detected by sensory neurons in the 
head are integrated and transduced through guanylyl cyclase and various 
other signal transduction pathways (Fielenbach and Antebi, 2008; Antebi, 
2013). These pathways in turn modulate two major conserved endocrine 
pathways, TGF-β and insulin/IGF signaling (IIS). In favorable environments, 
TGF-β and insulin/IGF peptide hormones are secreted from sensory neurons, 
and subsequently act on steroidogenic tissues to promote production of the 
DAF-12 ligands that were shown to be likely cholesterol-derived (Li, Kennedy 
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and Ruvkun, 2003; Ren et al., 1996). Binding of these steroidal ligands to 
DAF-12 is presumed to trigger recruitment of coactivator peptides, resulting 
normal developmental progression to adulthood. Conversely, in unfavorable 
environments, TGF-β and insulin/IGF peptides are downregulated, which 
results in repression of ligand biosynthesis. Unliganded DAF-12 then forms a 
complex with the DIN-1/SHARP corepressor and thereby specifies the long-
lived dauer stage (Ludewig et al., 2004). Thus, DAF-12 and associated co-
regulator complexes act as small-molecule hormone regulated molecular 
switches that specify two distinct life history modes, reproductive development 
and dauer diapause (Figure P.4). DAF-12 has also been implicated in 
regulation of fat metabolism, developmental timing and adult longevity 
(Fielenbach and Antebi, 2008) and together these reasons underline the 
importance of ascertaining the identity of the DAF-12 ligands. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
 
 
 
Figure P.4. Life history regulation by DAF-12. In favorable environments, 
uninhibited ligand production leads to liganded DAF-12 assembling with its 
putative coactivators to direct expression of genes involved in reproductive 
development. Under unfavorable conditions, unliganded DAF-12 together with 
its corepressor DIN-1 specify programs for dauer diapause.  
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That the DAF-12 ligands may be derived from cholesterol is suggested 
by multiple lines of evidence. C. elegans, being a cholesterol auxotroph, lacks 
the ability to synthesize cholesterol (Chitwood et al., 1999) and cholesterol 
deprivation produces Dauer constitutive (Daf-c) phenotypes (Gerisch et al., 
2001, Jia et al., 2002, Matyash et al., 2004). Next, worms missing both 
homologs of the human Niemann-Pick type C1 gene, a glycoprotein involved 
in cholesterol transport, arrest constitutively as dauers (Li et al., 2004). 
Additionally weak alleles of daf-9 mutant worms that are considered to be 
compromised in their ability to produce the DAF-12 ligand often show an 
enhanced dauer phenotype under cholesterol deprivation conditions (Gerisch 
et al., 2001; Jia et al., 2002). Furthermore, lipid extracts from wild-type worms 
can rescue daf-9 phenotypes (Gill et al., 2004). Based on a large body of 
evidence implicating cholesterol derivatives, in 2006, Motola et al., reported 
the identification of two cholestenoic acids as endogenous ligands of DAF-12 
(Figure P.5).    
 
Figure P.5. Putative ligands of DAF-12. Cholestenoic acid structures that 
were implicated as DAF-12 ligands by Motola et al. (2006) using genetic and 
biochemical techniques.  
 
 In order to identify the DAF-12 ligands, traditional natural products 
chemists might have resorted activity guided fractionation of the lipophilic 
worm extract with the objective of isolation of the active components in pure 
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form for complete spectroscopic structure determination (Schroeder, 2006). 
However Motola et al. pursued a different method originally based on 
screening a variety of commercially available steroids for DAF-12 binding 
using a cell-culture based transcriptional activation assay. The identified “hit” 
from this screen provided the clue that 3-keto functionality is essential for DAF-
12 binding. Subsequently, utilizing DAF-9’s role as the last step of the ligand-
biosynthetic pathway, two 3-keto steroids and known cholesterol metabolites 
known to be present in C. elegans, 4-cholesten-3-one and lathosterone, were 
hypothesized to be ligand precursors. Indeed, when incubated with DAF-9, the 
resultant product from both these precursors rescued daf-9(-) mutants. Based 
on these results and additional candidate screens, it was concluded that DAF-
9, a CYP27A1 homolog, oxidizes cholesterol metabolites at the C-26/C-27 
side chain, introducing a carboxylic acid moiety that was shown to be 
important for DAF-12 binding. While, the resultant molecules, termed 
dafachronic acids (DAs) (Figure P.5) are potently active at nM concentrations, 
Motola et al. and subsequent publications did not conclusively identify these 
compounds in C. elegans metabolite extracts, mainly because of the extremely 
low abundance of these molecules within the worms. Therefore, it ultimately 
remained unclear whether Δ4- and Δ7-dafachronic acid in fact represent the 
endogenous ligands of DAF-12. Apart from this oversight, this work is seminal 
especially since it is the first publication to report the de-orphanization of a C. 
elegans NHR and also provides evidence for the enzymatic activity of the 
cytochrome P-450, DAF-9.   
 Following the identification of DAF-9/CYP450 as a key steroid 
metabolizing enzyme and the description of putative structures of the 
endogenous DAF-12 ligands (Motola et al., 2006), a large number of 
publications have arisen in the last few years, speculating the biosynthetic 
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pathway of these cholesterol derived ligands. Dafachronic acids, due to their 
side chain carboxylation, structural modification in the C-7 position and the 
presence of an oxo-group at the 3-positions, are reminiscent of bile acids. Bile 
acids, like DAs, have been recently implicated in mammalian lifespan 
regulation, (Gems and Partridge, 2008; Amador-Noguez D et al., 2007).  
Without comprehensive knowledge of the true structures of the 
endogenous ligands, any putative biosynthetic pathway will always be 
vulnerable to massive changes. Currently, many of the identified components 
(enzymes) of the DAF-12 ligand biosynthetic pathway are indeed homologous 
to proteins that are involved in the bile acid biosynthetic pathway of higher 
organisms (Wollam et al., 2011; Wollam et al., 2012; Yoshiyama-Yanagawa et 
al., 2011; Motola et al., 2006) and have therefore often drawn comparisons 
between the DAF-12 ligand biosynthetic pathway in C. elegans and bile acid 
biosynthetic pathways in higher organisms. However, several separate new 
publications have reported the ambiguity about the exact role of HSD-1 and its 
putative function towards the biosynthesis of ∆4-DA (Dumas, 2010; Wollam, 
2012) and the need for further detailed investigation for the complete 
characterization of this and other enzymes in terms of their sterol profile and 
role in the DAF-12-ligand biosynthesis, is evident.  
 Due to its central role in C. elegans development, metabolism and 
lifespan, unambiguous clarification of the identity of DAF-12 ligands is of 
central importance to the field, along with a detailed characterization of the 
associated biosynthetic machinery. But this will still leave us, the scientific 
community, with 283 other NHRs that are orphan. Consequently, a systematic, 
analytical approach needs to be developed for unambiguous identification of 
endogenous ligands for other orphan nuclear receptors in C. elegans and 
other higher organisms.  
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AHR-1 and the tryptophan degradation pathway in C. elegans 
While there are 284 NHRs in C. elegans, of which only fifteen have 
clear homologs in other species, there are still other types of small-molecule-
ligand mediated transcription factors that are conserved between C. elegans 
and higher animals. One such example is the Aryl Hydrocarbon Receptor 
(AhR) which belongs to the basic helix-loop-helix (bHLH)/PAS (Per/Arnt/Sim) 
family of transcription factors (Lindsey et al., 2012). Although structurally 
dissimilar from NHRs, AhR is well known for mediating transcriptional 
regulatory effects originating from environmental toxins. In fact, it was 
originally identified (Poland et al., 1976) in a study of dioxin toxicity as an 
intracellular receptor in mammalian cells that binds 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD). More recently, dioxins and related compounds, including 
their interaction with the AhR, have been implicated in cancer, hepatotoxicity, 
birth defects, and immunological deficiencies in a variety of vertebrates, and all 
of these pathologies are due to defects in AhR activation (Schmidt and 
Bradfield, 1996; Whitlock et al., 1999). The mechanism of AhR action is similar 
to that described for other ligand-activated receptors and was determined by 
studies on AhR-mediated CYP1A1 gene expression (Ko et al., 1996). When 
not bound to a ligand, AhR is cytosolic and associated with heat shock 
proteins and prostaglandin E synthase 3, which together protects the receptor 
from proteolysis and prepares it for ligand binding (Kazlauskas et al., 2001). 
Upon ligand binding, the AhR translocates into the nucleus and forms a 
heterodimer with its partner, AhR nuclear translocator (ARNT). This complex 
then binds to specific response elements in target gene promoters to induce 
transcriptional activation in response to binding of specific ligands (Guyot et 
al., 2013).  The appreciation that the AhR is important for development and the 
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finding that it can elicit different responses when bound to a diverse variety of 
ligands, has refueled interest in the search for bonafide “endogenous” ligands 
for AhR (Ngyuen et al., 2008). Therefore, chemical identification of the 
endogenous small-molecule modulators of this receptor will make a major 
contribution towards understanding development as well as immune and 
xenobiotic responses in higher organisms and will provide insights into the 
therapeutic potential that may arise from modulating this system.  
While a large body of literature exists regarding the binding ability of 
exogenous molecules to AhR, search for endogenous activators of AhR has 
only just begun (Nguyen et al., 2008; Guyot et al., 2013). Heart and lung 
extracts (Chiaro et al., 2007) have been shown to contain AhR activators and 
several molecules such as arachidonic acid, leukotrienes, heme molecules, 
and UV photoproducts of tryptophan have been described as putative 
endogenous ligands (Nguyen et al., 2008). Among the most important studies, 
a tryptophan derivative, 6-formylindolo[3,2-b]carbazole (FICZ), with a high 
affinity for the AhR has been identified as an activator of CYP1A1 
transcription. Another tryptophan metabolite, kynurenine, has been reported to 
bind the AhR and was implicated in the development of brain tumors (Optiz et 
al., 2011). More recently, indole 3-aldehyde was reported as an endogenous 
AhR ligand, regulating gut microbial immunity (Zelante et al., 2013).  
However, no information is available about the endogenous ligands of 
AhRs for invertebrates. Specifically in C. elegans, where AhR has been shown 
to regulate neuronal development (Qin et al., 2004), it has been reported that 
TCDD does not bind to the AhR homolog, AHR-1. If AHR-1 does have an 
endogenous, small-molecule activator, its spectrum of ligands is potentially 
different from that of the mammalian receptor. From the point of view of 
chemists interested in small-molecule mediation of animal biology, 
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identification of AHR-1 ligands therefore provides an interesting challenge 
because of a) the diversity of ligand structures in mammals and b) the 
differences in functional outputs to AHR activation currently discovered in C. 
elegans. To address the first, a closer look at the structures of the putative 
mammalian ligands allows us to hypothesize that a deeper understanding of 
the tryptophan metabolites and their involvement in pathways that may be 
regulated by AhR is necessary. 
Tryptophan, the rarest essential amino acid, exists as L-tryptophan in all 
proteins (Rongvaux et al., 2003) but has been shown to exist as D-tryptophan 
in certain secreted peptides (Gadupudi et al., 2011). There are three main 
pathways that catabolize L-tryptophan: the serotonin, indole and kynurenine 
pathways. These catabolic pathways are extremely important for the 
generation of multiple significant metabolites including the ubiquitous enzyme 
co-factor Nicotine Adenine dinucleotide (NAD), the neurotransmitter serotonin 
and the vitamin niacin (Stone et al., 2012). In mammals, the kynurenine 
pathway catabolizes ~90% of L-tryptophan, and is controlled by two rate-
limiting enzymes, tryptophan dioxygenase (TDO) and indoleamine-2,3 
dioxygenase (IDO) (Gadupudi et al., 2011). Both IDO and TDO catalyze the 
same reactions, but TDO is highly substrate specific for L-tryptophan whereas 
IDO can also catalyze the D-isomer as well. 
Since the discovery of NAD as a product of the kynurenine pathway 
many years ago, little attention has been paid to the biological functions of 
kynurenine pathway intermediates including kynurenine itself, one of the 
putative ligands of mammalian AhR. Only recently, several investigations have 
shown that kynurenine and its derivatives are both biologically active and 
significant, and may play important roles in multiple ageing and age-related 
diseases (Figure P.6) (van der Goot and Nollen, 2013).  
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Figure P.6. Tryptophan metabolism in health and disease. Tryptophan 
metabolism regulation is cell-type dependant and controlled both locally or 
systemically. Tryptophan metabolism plays a role in neuronal activity, immune 
regulation and behavior. (Figure adapted from van der Woot and Nollen, 2013) 
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While more recent work in model organisms has begun to examine the role of 
kynurenines in animal biology, very little work has been carried out in C. 
elegans on the kynurenine pathway. In 1970s a class of mutants was 
discovered, known as Flu mutants, due to their altered auto-fluorescent 
properties. The mutations have not been cloned and only provisionally 
mapped to different linkage groups, but enough information has been reported 
to unravel the functions of at least two of these genes, flu-1 and flu-2, 
hypothesized to encode for the kynurenine-3-hydroxylase and kynureninase 
respectively (Nollen, 2012; Babu and Siddiqui, 1973) (Figure P.7). The 
kynurenine pathway and the flu mutants therefore provide an excellent 
opportunity to utilize metabolomics approaches to understand how genetic 
changes can effect changes in the metabolome. Investigating the tryptophan 
pathway in C. elegans will not only provide a new opportunity to discover novel 
components of the tryptophan degradation pathway but this process will set 
the stage for a comprehensive screen for the presence of Ahr-1 ligand(s) 
within the C. elegans metabolome. 
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Figure P.7. Kynurenine Pathway. Schematic representation of the 
kynurenine pathway in C. elegans and humans. Human genes are shown in 
gray while ortholog C. elegans genes are shown in black. (Figure adapted 
from van der Goot et al., 2012) 
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2D-NMR Based Comparative Metabolomics as a new tool for 
understanding small molecule metabolism in living systems.  
The study of diverse signaling pathways in C. elegans presents a 
fantastic opportunity to understand the role of small molecule signals and their 
biosynthesis in animal biology. However the common theme in all these 
investigations is the need to define the structural identities of the involved 
small-molecule ligands or metabolites. Therefore it is necessary to develop a 
largely unbiased technique that will allow us to unambiguously determine 
these structures from complex mixtures with minimal effort and time spent on 
isolation of pure natural product from the natural material. One of the 
techniques that has been developed in the Schroeder lab for this purpose is a 
comparative metabolomics approach named DANS or Differential Analysis by 
2D NMR Spectroscopy.  DANS allows for comparison of metabolomes derived 
from different genotypes and can greatly accelerate the identification of 
compounds whose production depends on a specific genomic background, 
because it reduces the need for extensive chromatographic fractionation; a 
major cause of compound loss due to degradation or decomposition in 
traditional structure elucidation schemes (Forseth and Schroeder, 2011).  
 2D-NMR can be conveniently used for the structural elucidation of 
several reactive, oligocyclic alkaloids derived from ants (Schroeder et al., 
1996; Schroeder et al., 1996).  More recently however, the DANS method has 
been used successfully in the elucidation of metabolites and biochemical 
pathways in fungi as well as C. elegans (Schroeder et al., 2007; Pungaliya et 
al., 2009; Forseth et al., 2011; Forseth et al., 2012; Robinnette et al., 2012).  
These examples have demonstrated the utility of a specific type of 2D-NMR 
spectrum (“dqfCOSY”) for compound identification via DANS, including the 
identification of synergistic components of the C. elegans dauer and mating 
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pheromones (Pungaliya et al., 2009, Srinivas et al., 2010, Forseth et al., 
2011).  
Encouraged by the success of this technique and intrigued by the 
important roles that nematode derived small-molecules play in regulating 
development, reproduction, life span and onset of death, this dissertation 
utilizes Differential Analysis by 2D NMR Spectroscopy to study the steroid 
signaling pathway and the tryptophan degradation pathway in C. elegans.  
 In chapter 2, the author of this dissertation describes the development 
of a blueprint for the unambiguous identification of steroidal ligands of the C. 
elegans NHR, DAF-12. In collaboration with Neelanjan Bose (Schroeder Lab) 
and supported by other members of the Schroeder Lab, as well as our 
collaborators in the labs of Adam Antebi, (Max PIanck Institute for Biology of 
Aging, Cologne) and Patrick Hu (University of Michigan), the author describes 
the discovery of two novel endogenous activators of DAF-12, along with the 
identification of another steroidal ligand which had been previously proposed 
using biochemical investigations (Motola et al., 2006) (Figure P.8). This work 
is the first example of identification of endogenous NHR ligands from complex 
natural mixtures using NMR spectroscopic methods and provides a roadmap 
for similar studies to be carried out for other C. elegans and mammalian 
orphan NHRs. 
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Figure P.8. Identification of novel steroid ligands for the NHR DAF-12.  
 
 In Chapter 3, the author in collaboration with Joshua Wollam (Adam 
Antebi Lab) and supported by members of the Schroeder and Antebi Labs, 
investigate the biosynthetic pathway of the identified endogenous DAF-12 
ligands. This work provides evidence toward a major revision of the currently 
accepted ligand biosynthetic pathway and discovers new roles for previously 
proposed components of the pathway. Additionally this work also identifies the 
role of a novel cytochrome P450 in the DAF-12-ligand biosynthetic scheme, 
underlining the importance of investigating small-molecule signaling in living 
systems to uncover novel mechanisms or components.  
 In Chapter 4, the author describes the identification of a novel class of 
anthranilic acid derivatives (members of the tryptophan degradation pathway), 
which are responsible for a striking blue fluorescence that is emitted from 
intestinal cells of C. elegans and other nematodes, moments before death 
(Figure P.9). The identification of the “death fluorescence” phenomenon was 
carried out by Cassandra Coburn (David Gems Lab, University College 
London) and this work has been subsequently published in PLoS Biology 
earlier this year (Coburn et al., 2013). Additionally, this work has led to 
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preliminary investigations of the kynurenine pathway in C. elegans using 
DANS and initial results suggest the existence of previously unreported 
enzymatic components in this pathway.  
 
Figure P.9. Identification of death fluorescence in C. elegans using DANS 
methodology.  
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CHAPTER 2 
 
COMPARATIVE METABOLOMICS REVEALS ENDOGENOUS LIGANDS OF 
DAF-12: A NUCLEAR HORMONE RECEPTOR REGULATING C. ELEGANS 
DEVELOPMENT AND LIFESPAN 
 
Introduction:  
Nuclear hormone receptors (NHRs) are DNA-binding proteins that 
regulate gene expression in response to environmental, nutritional and 
developmental signals. The activity of a large proportion of these evolutionarily 
conserved, transcription factors is selectively and reversibly modulated by 
small-molecule ligands. Even very small changes in ligand structures may 
result in dramatic changes of transcriptional activity and specificity (Brown and 
Slatopolsky, 2008; Singarapu 2011) and therefore, precise knowledge of the 
structure of these small-molecule NHR ligands is essential for understanding 
their role in controlling diverse aspects of metazoan metabolism, cell 
differentiation, development and aging. However, despite this need for a 
comprehensive understanding of ligand structures  and their biosynthetic 
pathways to understand NHR function (Mangelsdorf, 1995; Wollam and 
Antebi, 2011), the endogenous ligands of many NHRs have remained poorly 
characterized, often due to very low abundance of these molecules in highly 
complex animal metabolomes (Schupp and Lazar, 2010).  
 The free living nematode C. elegans has 284 NHRs, allows easy 
genetic manipulation, and can be grown in substantially large quantities, 
providing an unique opportunity to investigate structures, biosynthesis, and 
functions of NHR ligand in a relatively simple model system (Hulme and 
Whitesides, 2011; Taubert et. al., 2010). In C. elegans, DAF-12, a homolog of 
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vertebrate Vitamin D (VDR) and liver X receptors (LXR), functions as a ligand-
dependent switch that control both adult lifespan and larval development 
(Antebi, 2000; Fielenbach, 2008; Kenyon, 2010; Shen, 2012). The 
biosynthesis of the ligands of DAF-12, hypothesized to be of steroidal origin 
(Matyash, 2004; Gerisch, 2001; Jia, 2002), is controlled by a complex 
endocrine signaling network, many components of which, appear to be highly 
conserved between C. elegans and mammals (Fielenbach and Antebi, 2008). 
Perception of environmental stimuli by chemosensory neurons regulates 
signaling via the conserved insulin/IGF and TGF-β pathways, which converge 
on genes implicated in DAF-12-ligand biosynthesis (Figure 2.1). Under 
unfavorable conditions such as overcrowding or scarcity of food, ligand 
biosynthesis is suppressed, and unliganded DAF-12 interacts with its co-
repressor DIN-1 (Ludewig et al., 2004). The resulting transcriptional repression 
of DAF-12 target genes causes developmental arrest and entry into a highly 
stress-resistant larval stage called the dauer diapause (Gems et al., 1998; 
Larsen et al., 1995; Schaedel et al., 2012) (Figure 2.1). In contrast, favorable 
environmental conditions trigger upregulation of DAF-12 ligand biosynthesis. 
DAF-12 ligand binding then results in dissociation of the corepressor DIN-1 to 
allow expression of DAF-12 target genes, promoting rapid developmental 
progression from larvae to reproductive adults (Fielenbach and Antebi, 2008; 
Ludewig et al., 2004) (Figure 2.1). Additionally, ligand-dependent activation of 
the DAF-12 target genes mir-84 and mir-241, two microRNAs of the conserved 
let-7 family (Bethke et al., 2009; Hammell et al., 2009), is required for lifespan 
regulation in response to signals from reproductive tissues (Kenyon et al., 
2010; Yamawaki et al., 2010). These findings suggest that metazoan lifespan 
is coupled to the gonad via NHR signaling (Shen et al., 2012).  
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Figure 2.1. Role of DAF-12 in the dauer pathway. Under favorable 
conditions, signaling via the insulin/IGF and TGF-β pathways drive 
biosynthesis of steroidal DAF-12-ligands. Liganded DAF-12 promotes 
development, in part via transcription of the let-7-family microRNA's mir-84 and 
mir-241. Under unfavorable conditions, ligand biosynthesis is inhibited, 
resulting in interaction of unliganded DAF-12 with its co-repressor DIN-1 and 
target gene repression (Ludewig et al., 2004) 
 
 
Based on extensive biochemical studies, two bile acid-like steroids 
named Δ4- and Δ7-dafachronic acid were proposed as endogenous ligands of 
DAF-12 (Figure 2.2) (Motola et al., 2006). Central to the identification of these 
steroids named as dafachronic acids (DAs), as DAF-12 ligand candidates 
were precursor studies in which a variety of 3-keto steroids were identified as 
substrates for the cytochrome P450, DAF-9, which had been shown to act 
upstream of DAF-12 in DAF-12-ligand biosynthesis (Gerisch et al., 2001; Jia et 
al., 2002; Motola et al., 2006). DAF-9 was further shown to act on the 
sidechain in these cholestenones introducing a terminal carboxyl group 
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(Figure 2.2) (Motola et al., 2006). In a separate study, a DAF-12-activating 
isomer of 3β-hydroxy cholest-5-enoic acid was detected in C. elegans 
metabolite extracts (Held et al., 2006). However, given the very low 
concentrations of the putative DAF-12-ligands in C. elegans, isolation and full 
spectroscopic characterization of these compounds was not pursued (Motola 
et al., 2006).  
 
 
 
 
  
 
Figure 2.2. Previously described DAF-12-ligands and proposed 
biosynthetic pathway - (Dumas et al., 2010; Gerisch et al., 2007; Patel et al., 
2008; Rottiers et al., 2006; Williams et al., 2010; Wollam et al., 2011; 
Yoshiyama-Yanagawa et al., 2011). DAF-12-ligand biosynthesis is 
downregulated in response to dauer pheromone (Schaedel et al., 2012), a 
blend of ascarosides, e.g. the shown ascr#2 (red).  
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In this chapter, the author shows how by developing an unbiased, comparative 
metabolomics approach to specifically address the problems created by low 
abundance of the target molecule in a complex animal metabolome, several 
novel and endogenous steroidal ligands of DAF-12 are identified. This 
approach utilizes the Differential Analysis by 2D-NMR Spectroscopy (DANS) 
technique to compare metabolomes of ‘ligand-deficient’ and ‘ligand-rich’ 
animals and provides a blue-print for the systematic identification of ligands of 
other C. elegans and mammalian NHRs.  
 This work was done in collaboration with Neelanjan Bose (Frank 
Schroeder Lab, Cornell University). Synthetic compounds were provided by 
Joshua Judkins and some of the bio-assays were carried out in collaboration 
with Dr. Joshua Wollam (Adam Antebi Lab, MPI Cologne) Dr. Axel Bethke 
(Frank Schroeder Lab, Cornell University) and Dr. Kathlyn J. Dumas (Patrick 
Hu Lab, University of Michigan).  
 
Developing a systematic blueprint for identification of endogenous DAF-
12 ligands:  
 Since all of the earlier body of work associated with finding the identity 
of DAF-12 ligands relied on classical genetics and biochemical experiments, 
our first objective was to identify the endogenous ligands of DAF-12 based on 
direct and unambiguous spectroscopic evidence obtained from analysis of the 
C. elegans metabolome. For this purpose we employed a combination of 
activity-guided fractionation and NMR-based comparative metabolomics via 
DANS (Differential Analyses by 2D NMR Spectroscopy) (Figure 2.3). 2D NMR 
spectroscopy provides a largely unbiased overview of metabolome 
composition, and comparing 2D NMR spectra of different mutant backgrounds 
via DANS often allows the detection and partial identification of very minor 
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metabolites such as signaling molecules (Pungaliya et al., 2009; Forseth and 
Schroeder, 2011). DANS relies on correlating changes in the metabolome with 
perturbations made in the genome, for compound identification and thereby 
reduces the need for extensive fractionation, which frequently results in loss of 
activity or the introduction of artifacts (Forseth and Schroeder, 2011). We 
envisioned that this approach could be applied to identify DAF-12-ligands if 
one compared a C. elegans mutant metabolome lacking DAF-12-ligands with 
the metabolome of animals that produces DAF-12-ligands abundantly.  
For this DANS-based ligand identification, we chose daf-9;daf-12 double 
mutants as the ligand-deficient strain and daf-22 mutants as a ligand-rich 
reference strain. Even though daf-9;daf-12 double mutants do not produce 
DAF-12-ligands, they bypass the dauer stage, because lack of DAF-12 
prevents the execution of genetic programs required for dauer formation 
(Gerisch et al., 2004) and therefore can be grown in large volumes that allows 
NMR spectroscopic analyses of less abundant metabolites. daf-22 mutant 
worms develop normally to adulthood, but are defective in the biosynthesis of 
the dauer-inducing ascarosides (Butcher et al., 2009; von Reuss et al., 2012), 
which we hypothesized may adversely affect DAF-12-ligand production in wild-
type liquid cultures (Figure A.1). Downregulation of DAF-12-ligand 
biosynthesis by ascarosides is also suggested by the finding that exposure to 
high concentrations of dauer pheromone abolished expression of DAF-9, one 
of the key enzymes in the proposed biosynthetic pathway of DAF-12-ligands 
(Schaedel et al. 2012). 
 In preparation for DANS analysis, metabolome extracts obtained from 
large scale, mixed stage, liquid cultures of the wild-type, daf-9;daf-12 and daf-
22 strains were fractionated using an automated, highly reproducible 
chromatography system (Appendix A). The resulting parallel sets of 
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metabolome fractions were assessed for DAF-12-ligand content using both in 
vivo and in vitro bioassays (Figure 2.3). The in-vivo assay used daf-9(dh6) 
worms, which are defective in DAF-12-ligand production. In the absence of 
exogenously added DAF-12-ligand or a suitable precursor, developing daf-
9(dh6) worms arrest as dauer larvae, because DAF-12 constitutively interacts 
with its corepressor DIN-1 (Gerisch et al., 2004; Gerisch et al., 2007; Ludewig 
et al., 2004). The assay scored the ability of added metabolome fractions to 
rescue the arrested dauer larvae and promote development to adulthood, 
providing a measure for the presence of a DAF-12 ligand or suitable precursor 
in the exogenously added fractions that would dissociate the DAF-12/DIN-1 
corepressor complex. The in-vitro assay measured DAF-12 transcriptional 
activation of a luciferase reporter in HEK-293T cells that were co-transfected 
with full-length DAF-12 and the reporter construct (Bethke et al., 2009). This 
assay provided a measure for ligand-dependent interaction of DAF-12 with 
mammalian coactivator(s) endogenous to the cell line. Both of these assays 
consistently showed activity for three groups of daf-22 and wild type 
metabolome fractions (regions I-III in Figure 2.3), suggesting the presence of 
DAF-12-ligands or precursors, whereas all daf-9;daf-12 fractions were inactive 
in both assays, as expected based on previous work (Gerisch et al., 2004; 
Gerisch et al., 2007; Motola et al; 2006). As anticipated, daf-22 fractions were 
significantly more active in both assays than the corresponding wild-type 
fractions, suggesting much higher production of DAF-12-ligands in daf-22 
mutants (Figure 2.3, Figure A.1).  
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Figure 2.3. Detection of DAF-12-ligands in C. elegans mutant 
metabolomes. (A) Fractionation of active, ligand-rich daf-22 and inactive daf-
9;daf-12 metabolomes is followed by 2D-NMR-based comparative 
metabolomics of active fractions. (B) Assessment of DAF-12-ligand content 
using (Top) an in vitro luciferase assay in HEK-293T cells transfected with full-
length DAF-12 and a mir84p-luciferase reporter vector and (Bottom) in vivo 
daf-9(dh6) dauer rescue assays. (C) daf-9;daf-12 metabolome fractions are 
inactive in the luciferase assay. 100 nM Δ7-DA is used as a positive control.(D) 
Luciferase assays of daf-22 metabolome fractions reveal three active 
regions.(E) Daf-9(dh6) dauer rescue assays of daf-22 metabolome fractions 
show activity in the same three regions. For worm images of scored 
phenotypes and additional activity data see Figure A.1. 
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DANS reveals steroids with unexpected structural features:  
 Two-dimensional (2D) NMR spectra of the most active group of daf-22 
fractions, active region I, revealed the presence of long-chained ascarosides 
(Pungaliya et al., 2009), in addition to a complex mixture of fatty acids, 
glycerides, other lipids, and several epidioxy sterol derivatives, (Figure A.2) 
(Gunatilaka et al., 1981; Sera et al., 1999), all of which were also present in 
similar concentrations in corresponding daf-9;daf-12 metabolome fractions. 
However, a more rigorous inspection of region I 2D NMR spectra revealed 
several sets of signals that were consistently absent in daf-9;daf-12, and thus 
appeared to be daf-9-dependent (Figure 2.4). Subsequent analysis of these 
differential signals strongly suggested steroidal structures. Because of their 
extremely low concentrations, detailed characterization of the putative daf-9-
dependent steroids required additional fractionation via HPLC, which resulted 
in two active samples each containing 1-2% of daf-9-dependent components 
(Figure 2.5).  
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NMR-spectroscopic analysis of the most active fractions showed a distinct set 
of daf-9-dependent signals at 5.9 and 7.0 ppm with a coupling constant of 10 
Hz, which strongly suggested the presence of an unusual Δ1-unsaturated 3-
keto steroid (Figure 2.6). Comparison with literature data suggested 3-
oxocholesta-1,7-dienoic acid (“Δ1,7-DA”), which had not previously been 
described from worms, in addition to smaller amounts of the known Δ7-DA 
(Figure 2.6) (Motola et al., 2006). Δ1-unsaturated steroids are rare in nature, 
and we are aware of only one other example in animals, the identification of 
(25S)-3-oxocholesta-1,4-dienoic acid from the Indonesian soft coral, Minabea 
sp. (Wang et al., 2009).  
  
 48 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6. Detection of endogenous DAF-12-ligands via DANS and 
subsequent confirmation by SIM-GC/MS. dqfCOSY spectrum of inactive 
daf-9;daf-12 metabolome fraction corresponding to active region I. Enlarged 
section (upper left) compares daf-9;daf-12 with corresponding daf-22 section, 
showing one of the differential crosspeaks (red) that led to identification of Δ1,7-
DA, next to non-differential signals representing a metabolite present in both 
daf-9;daf-12 and daf-22, an epidioxy sterol (blue). Enlarged section (lower 
right) shows example crosspeaks from the comparison of the strm-1 (vide infra 
Chapter 2) and daf-9;daf-12 metabolomes, showing signals (green) 
characteristic for Δ7-DA in the strm-1 spectrum but not the daf-9;daf-12 
spectrum.  
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Authentic synthetic samples of Δ1,7- and Δ7-DA were synthesized de novo in 
our lab by Joshua Judkins and the structural assignments were confirmed by 
comparison of spectroscopic data and GC/MS chromatographic retention 
times with those of the synthetic samples (Figure A.3).  Previous work had 
also suggested the specificity of the relative configuration at C-25 of the side 
chain and to determine the relative configuration of the chiral centers at 
position 25 in the sidechains of Δ7-DA and Δ1,7-DA, we carried out an NMR 
spectra based titration experiment using synthetic samples of (25S)- and 
(25R)-diastereomers with those of the natural samples. These analyses 
unambiguously established the configuration of natural Δ7-DA and Δ1,7-DA as 
(25S) (FIGURE 2.8).  
 
 
 
 
 
 
 
 
 
 
Figure 2.7. Absolute configuration of dafachronic Acids. (Left) NMR-
spectroscopic determination of the absolute configuration at C-25 in natural 
Δ7-DA. C-18 singlet region of 1H NMR spectra (600 MHz, pyridine-d5) of 
natural Δ7-DA and mixtures with synthetic (25R)-Δ7-DA and (25S)-Δ7-DA. 
(Right) NMR-spectroscopic determination of the absolute configuration at C-
25 in natural Δ1,7-DA. C-18 singlet region of 1H NMR spectra (600 MHz, 
pyridine-d5) of natural Δ
1,7-DA and mixtures with synthetic (25R)-Δ1,7-DA and 
synthetic (25S)-Δ1,7-DA 
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Comparative analysis of active region II using a similar workflow 
showed that this region contained yet another novel steroid in much lower 
quantities. To conclusively identify the extremely low abundant, active 
component in this region, we had to acquire a 900 MHz 2D-NMR Spectrum for 
additional sensitivity, which led us to identify the presence of another novel 
daf-9-dependent cholestenoic acid derivative, featuring a rather unusual 3α-
hydroxylation: (25S)-3α-hydroxy cholest-7-enoic acid ("3α-OH-Δ7-DA") (Figure 
2.8).  
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Figure 2.8. Detection of 3α-OH-Δ7-DA in active region II. (a) Section of 
dqfCOSY spectrum (900 MHz, CDCl3) indicating the presence of 3α-OH-Δ
7-
DA in HPLC-enriched fraction of active region II. (b) Section of dqfCOSY 
spectrum (600 MHz, CDCl3) of synthetic 3α-OH-Δ
7-DA. Characteristic 
crosspeaks of 3α-OH-Δ7-DA are boxed red; signals from other metabolites are 
boxed blue.  
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Once again the comparison of 2D-NMR spectra of the natural material 
to that of the synthetic sample confirmed the structural assignments and the 
GC/MS fragmentation pattern of 3α-OH-Δ7-DA strongly suggests that it is 
identical to the heretofore unidentified isomer of (25S)-cholest-3β-enoic acid 
previously reported as a DAF-12-ligand by Held et al. (Figures A.7 and A.8) 
(Held et al., 2006). As all 3-hydroxylated steroids previously described from C. 
elegans feature 3β-configuration, the identification of 3α-OH-Δ7-DA is very 
surprising and suggested novel enzymatic activities in the biosynthetic scheme 
of DAF-12 Ligands (Chapter 3). We subsequently inspected both active and 
inactive C. elegans metabolome fractions for the presence of the 
corresponding 3β-stereoisomer, 3β-OH-Δ7-DA (Figure 2.9); however, 3β-OH-
Δ7-DA could not be detected in either wild-type or daf-22 mutant metabolomes, 
indicating that production of 3α-OH-Δ7-DA is highly selective.  
 
 
Figure 2.9. Identification of 3α-OH-Δ7-DA in active region II. GC/MS total 
ion chromatograms (TIC) of synthetic 3α-OH-Δ7-DA, synthetic 3β-OH-Δ7-DA, 
and natural 3-OH-Δ7-DA TMS derivatives. The GC retention times for the 
natural compound matches precisely with that of synthetic 3α-OH-Δ7-DA and 
is distinctly different from that of the 3β-isomer. (*) indicates small amounts of 
impurities in the synthetic 3β-OH-Δ7-DA sample. 
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Active region III, representing a series of metabolome fractions with 
comparatively low daf-9(dh6) dauer rescue activity, revealed trace quantities of 
glucosides of Δ1,7-DA and Δ7-DA that were not characterized further as part of 
this study. However, future investigations on this active region would be 
extremely informative especially with the recent findings of multiple 
glycosylated derivatives of other C. elegan derived small molecules. 
 Using both 2D-NMR spectroscopy and SIM-GC/MS, we also checked 
the daf-22 mutant and wild-type metabolomes for the presence of the 
previously reported Δ4-DA. We were unable to detect Δ4-DA in any of the 
analyzed C. elegans metabolome samples, whereas metabolome fractions 
spiked with trace quantities of synthetic Δ4-DA confirmed the sensitivity of our 
MS based detection methods (Figure 2.10). We then considered the 
possibility that our growth conditions may have affected the production of the 
putative precursor of Δ4-DA, 4-cholesten-3-one (Motola et al., 2006; Patel et 
al., 2008). However, analysis of wild-type metabolome samples by GC-MS and 
NMR spectroscopy revealed that 4-cholesten-3-one is as abundant as 
lathosterone (Figure 2.11, Figure A.11), a putative precursor of Δ7-DA 
(Motola et al., 2006, Wollam et al., 2012), suggesting that absence of Δ4-DA is 
not the result of a lack of suitable precursors. Therefore, it appears that Δ4-DA 
may not play a significant physiological role as a DAF-12 ligand, although its 
transient or very low-level production cannot be excluded. 
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Figure 2.10. SIM-GC/MS analysis did not reveal Δ4-DA as a significant C. 
elegans metabolite.  SIM-GC/MS total ion chromatograms (TIC) of synthetic 
Δ4-DA methyl ester, 1% injection of methylated inactive fraction 26 from daf-22 
to which trace amounts of synthetic Δ4-DA (100 ng, ~20-fold less than Δ7-, 
Δ1,7-DAs in active metabolome fractions) had been added, and 100% injection 
of a methylated and HPLC-enriched natural fraction matching the LC retention 
time of synthetic Δ4-DA. 
 
Figure 2.11.  Identification of 4-cholesten-3-one and lathosterone from 
daf-22. Comparison of representative sections of 1H-NMR spectra of enriched 
fractions from daf-22 with synthetic 4-cholesten-3-one and lathosterone 
revealed the presence of the 3-keto-steroids  in the natural sample.  
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Newly identified steroids are biologically active: 
 In order to confirm that the newly identified endogenous steroid 
molecules were indeed physiologically relevant DAF-12 ligands, we next 
investigated the biological properties of synthetic samples of the identified daf-
9-dependent steroids (Figures 2.12). Bioassays with synthetic samples of 
Δ1,7-DA showed that this compound activates DAF-12 in mammalian cells 
(EC50 = 146 nM) and that its potency in the daf-9(dh6) dauer rescue assay is 
similar (EC50 = 2 nM) or slightly higher than that of Δ
7-DA (Figure 2.12 and 
Table A.1). Similarly, 3α-OH-Δ7-DA was active in both the in vivo and in vitro 
assays, whereas its 3β-stereoisomer did not activate DAF-12 in mammalian 
cells at any of the concentrations tested and rescued the daf-9(dh6) dauer 
phenotype only at very high concentrations (Figure 2.12).  
We also tested the two most abundant daf-9-dependent compounds for 
their effect on lifespan in germline-deficient glp-1 mutant worms. Germline-
deficient glp-1 mutant worms live up to 60% longer than wild-type; however, 
this lifespan extension has been shown to depend on functional DAF-12 and 
DAF-12-ligand biosynthetic enzymes (Arantes-Oliviera et al., 2003; Yamawaki 
et al., 2010) . Correspondingly, ligand-deficient glp-1;daf-36 double mutant 
worms lack the glp-1 lifespan extension phenotype (Gerisch et al., 2007). We 
found that both Δ7-DA and Δ1,7-DA fully restore glp-1-dependent lifespan 
extension in glp-1;daf-36 double mutants (Figure 2.12 and Figure A.9).  
For quantification of the identified daf-9-dependent steroids, we 
employed highly sensitive SIM-GC/MS detection of characteristic mass 
spectrometric fragments of volatile methylated or silylated derivatives 
(Extended Experimental Procedures). SIM-GC/MS showed that Δ1,7-DA is 
slightly more abundant than Δ7-DA in daf-22 worms, whereas in wild-type 
animals Δ1,7-DA is more than twice as abundant as Δ7-DA, with concentrations 
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(averaged over the worm bodies) of 40 nM and 130 nM for Δ7-DA and Δ1,7-DA, 
respectively (Figure 2.12, Table A.1). 3α-OH-Δ7-DA occurs at about 3-5-fold 
lower concentrations than Δ7-DA in both wild-type and daf-22 mutants. Based 
on the specific activities determined for synthetic samples of Δ7-DA, Δ1,7-DA, 
and 3α-OH-Δ7-DA it appears that these three compounds can account for all of 
the activity in regions I and II in both wild-type and daf-22 metabolomes.  
To test whether the identified daf-9-dependent compounds constitute 
bona-fide ligands of DAF-12, we measured ligand dependent binding of DAF-
12 with the SRC1-4 peptide containing the nuclear receptor box ("NR box") 
motif of mammalian coactivator SRC-1 (Motola et al., 2006; Fukuyama et al., 
2006), using the Alphascreen technology. The Alphascreen is a proximity 
based biomolecular screening strategy commonly used for assessing direct 
binding ability of small molecules with nuclear hormone receptors (Glickman et 
al., 2002; Xu et al., 2002) among other interactions, and has been previously 
used for assessing binding affinity of dafachronic acids with DAF-12 (Motola, 
et al., 2006; Wang et al., 2009; Zhi et al., 2012). We found that Δ7-DA, Δ1,7-DA 
and 3α-OH-Δ7-DA effect concentration-dependent recruitment of SRC1-4, with 
EC50 values of 8 nM and 15 nM for Δ
7-DA and Δ1,7-DA, respectively, whereas 
affinity of 3α-OH-Δ7-DA was lower (EC50 = 200 nM, Figure 2.12 and Table 
A.1). These relative potencies of Δ7-DA, Δ1,7-DA and 3α-OH-Δ7-DA are similar 
to relative activities observed in the luciferase assay (Figure 2.12, Table A.1).  
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Figure 2.12. Biological activity of dafachronic acids. (A) Assessment of 
DAF-12 transcriptional activation in HEK-293T cells by the identified 
endogenous DAF-12-ligands. Luciferase assays were measured in triplicates 
and are shown with SD. (B) Daf-9(dh6) dauer rescue with the identified 
endogenous DAF-12-ligands at 27 °C. For each data point there were two 
replicates with 100 animals per replicate, error bars SD. (C) Both Δ7-DA (100 
nM) and Δ1,7-DA (100 nM) restore lifespan extension to glp-1 animals in daf-36 
null background. (D) Alphascreen assay for ligand-dependent recruitment of 
SRC1-4 peptide by DAF-12, showing fold activation of DAF-12 with different 
ligand candidates over control (ethanol). 
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Taken together, these results indicate that Δ1,7-DA and Δ7-DA are high-
affinity ligands of DAF-12 that promote reproductive development and adult 
longevity, whereas 3α-OH-Δ7-DA is of lower potency in promoting these 
phenotypes and Δ4-DA is not present at physiologically relevant 
concentrations. These findings indicate a) that previous hypotheses about 
DAF-12-ligand structures must be revised and b) that there exists at least two 
novel enzymes in the biosynthetic pathway of DAF-12 ligands that have not 
been identified. 
 
Conclusions and Discussion 
In this chapter, the author has shown how, using 2D-NMR based 
comparative metabolomics changes in the metabolome can be analyzed and 
correlated with perturbations in the genome. This study, utilizing C. elegans as 
a model organism, has provided a systematic blue print to identify small 
molecule ligands of NHRs, which control key life processes in metazoans. 
Unique among of the 284 NHRs in C. elegans, DAF-12 plays a central role in 
regulating reproduction, development, lifespan, fat-metabolism and other 
essential programs in nematodes, and therefore has been the object of a large 
number of studies in recent years. In contrast to earlier work that was primarily 
based on screening candidate structures our approach has finally revealed the 
real, endogenous ligands of this essential transcriptional regulator in C. 
elegans. 
 The newly identified, Δ1,7-DA, is not only the most abundant ligand in 
wild-type worms, but also more potent, and interestingly incorporates an 
unsaturation in the 1,2 position in the A-ring of the steroid moiety. 1,2 
unsaturated steroids are not common in animals and only one other example 
of the existence of this moiety in metazoans is known (Wang et al., 2009). 
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However, it is well known that the introduction of Δ1 unsaturation in natural 3-
keto steroids, e.g. testosterone and corticosteroids, can have pronounced 
effects on their biological properties (Counsell and Klimstra, 1962; Goulding 
and Flower, 2001). Analysis of X-ray structures of the DAF-12 ligand binding 
domain complexed with DAs have demonstrated that small structural changes 
in the A and B rings of the bound steroid have significant effects on ligand 
affinity to DAF-12 (Wang et al., 2009b; Zhi et al., 2012), suggesting that 
specific modifications in the steroid A-ring may serve to fine-tune DAF-12 
transcriptional regulation. Identification of the enzyme(s) introducing the Δ1-
double bond will play an important role in elucidating functional differences 
between Δ1,7- and Δ7-DA and may motivate re-analysis of mammalian 
metabolomes for the presence of endogenous Δ1-steroids. 
The additional identification of the 3α-OH-Δ7-DA creates a striking 
parallel to mammalian bile acid metabolism, which produces almost 
exclusively sterols with 3α configuration (Figure 2.13) (Russell, 2003). Given 
its stereoselective biosynthesis by an as-yet unknown enzyme, it is likely that 
3α-OH-Δ7-DA serves specific functions in DAF-12 signaling. Notably, 3β-OH-
Δ7-DA, which is absent in wild type worms is much less active in both the in 
vivo and in vitro assays. However, it should be noted that both the 
transcriptional activation assay in mammalian cell-culture and the Alphascreen 
assay (Figure 2.12) have limited cogency for judging the relative potency of 
different DAF-12 ligands in vivo, as both assays depend on recruitment of 
mammalian coactivators such as SRC-1, whereas in-vivo function of DAF-12 
is thought to involve ligand-dependent dissociation of the endogenous C. 
elegans corepressor DIN-1 followed by binding of yet unidentified co-activators 
(Ludewig et al., 2004). The identification of multiple endogenous small 
molecule regulators of DAF-12 in this study will accelerate the pursuit of yet 
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elusive DAF-12 interactors and other components of DAF-12-dependent dauer 
and lifespan regulation.  
 
Figure 2.13. Comparison of NHR signaling in nematodes and mammals. 
In nematodes, oxidation/epimerization in position 3, oxidation in position 7, and 
side chain oxidation produces ligands of the NHR DAF-12, whereas similar 
modification of the steroid skeleton in mammals produces bile acids that serve 
as ligands of farnesoid X receptor (FXR) (Russell, 2003). Although DAF-9 has 
often been assumed to act directly upstream of DAF-12, our results suggest 
that DAF-9 may act on a variety of different substrates,E including both 3-keto 
and 3-hydroxy sterols. Enzymes introducing the structural features highlighted 
in gray are not known. 
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CHAPTER 3 
 
COMPARATIVE METABOLOMICS ANALYSIS OF DA BIOSYNTHESIS 
MUTANTS REVEAL NOVEL PATHWAYS OF STEROID HORMONE 
PRODUCTION 
 
Introduction:  
 Prior to this study, none of the structures of the proposed DAF-12 
ligands had been confirmed based on comprehensive spectroscopic analysis 
and the previous chapter described how this study achieves the identification 
of endogenous DAF-12 ligands. However, based on the putative ligand 
structures (Motola, 2006; Δ4- and Δ7-dafachronic acids) a biosynthesis model 
has been developed (Figure 3.1) and the biochemical roles of genes proposed 
to function upstream of DAF-9 in DAF-12-ligand biosynthesis have been 
studied extensively (Dumas et al., 2010; Patel et al., 2008; Rottiers, 2006; 
Williams et al., 2010; Wollam et al., 2011; Yoshiyama-Yanagawa et al., 2011; 
Hannich et al., 2009).  
  In each of these studies it has been assumed that there are two 
distinct, parallel pathways emanating from exogenous cholesterol that leads to 
the biosynthesis of Δ4- and Δ7-dafachronic acid. DAF-12-ligand biosynthesis 
begins with oxidation of cholesterol by the Rieske-like oxygenase DAF-36 
yielding 7-dehydrocholesterol (Gerisch et al., 2007; Rottiers et al., 2006; 
Wollam et al., 2011; Yoshiyama-Yanagawa et al., 2011). 7-dehydrocholesterol 
is converted by an as yet unidentified enzyme to lathosterol, which is 
subsequently oxidized to the corresponding ketone, lathosterone, by the short-
chain dehydrogenase, DHS-16 (Wollam et al., 2012). Lathosterone is then 
converted to Δ7-DA by DAF-9 (Gerisch and Antebi, 2004; Gerisch et al., 2007; 
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Motola et al., 2006). In addition, a parallel pathway for the biosynthesis of Δ4-
DA involving the putative hydroxysteroid dehydrogenase, HSD-1, has been 
proposed (Dumas et al., 2010; Patel et al., 2008), although recent evidence 
suggests that HSD-1 has no role in the production of the putative precursor of 
Δ4-DA, 4-cholesten-3-one (Wollam et al., 2012), leaving its role in DAF-12 
ligand biosynthesis undetermined (Figure 3.1). However, with our recent 
findings in Chapter 2 that a) Δ4-dafachronic acid is not present in whole worm 
extracts in physiologically relevant concentrations; b) Δ1,7 -dafachronic acid is 
the most abundant dafachronic acid endogenously produced in C. elegans; 
and c) C. elegans, and presumably other nematodes (Zhi, 2012), possess the 
enzymatic machinery to manipulate the 3-position in the steroid A-ring as 
corroborated by the identification of 3α-OH-Δ7-DA it becomes imperative to 
reinvestigate the role of these putative steroid biosynthetic enzymes in the 
context of DAF-12-ligand biosynthesis. 
 More recent work has shown that the proposed DAF-12 ligands do not 
explain all DAF-12 associated functions and has suggested a functionally 
divergent biosynthetic network with the possibility of alternative DAs (Dumas, 
2010), a hypothesis confirmed by the results reported in the previous chapter. 
These results taken together indicate that the DAF-12-ligand biosynthetic 
pathway is more complex than originally thought and the identities of several 
enzymes, which likely constitute important regulatory nodes controlling DAF-
12 activity, still remain unknown,. 
 In this chapter, the author describes how utilizing a multidisciplinary and 
collaborative approach combining chromatographic separation; NMR 
Spectroscopy and GC/MS analysis (in collaboration with Neelanjan Bose, 
Frank Schroeder Lab and Daniel Magner, Adam Antebi Lab); chemical 
syntheses (in collaboration with Joshua Judkins, Frank Schroeder Lab); 
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genetic screening and biochemical methods (in collaboration with Joshua 
Wollam, Adam Antebi Lab), the sterol metabolome of C. elegans was 
analyzed. In the process, several striking pieces of evidence, including the 
identity of a novel cytochrome p450 involved in the biotransformation of DAF-
12 ligands were discovered, which reveal several novel pathways for DAF-12-
ligand production strongly suggesting that the accepted ligand-biosynthetic 
pathway require substantial revision.  
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Figure 3.1 Putative Biosynthetic Pathway of Dafachronic Acids.  Figure 
adapted from Wollam, 2012; Patel, 2008, Rottiers, 2006, Dumas, 2010 and 
this work (Chapter 2). 
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Comparative Metabolomics Suggest Tissue Specific Ligand 
Biosynthesis:  
 Intrigued by the extremely low abundance of the previously proposed 
DAF-12-ligand Δ4-dafachronic acid in C. elegans whole worm extracts we 
began our biosynthetic analysis analysis with profiling hsd-1mutants and hsd-
1;daf-22 double mutants, since HSD-1 has been proposed to be enzymatically 
responsible for the conversion of cholesterol to Δ4-cholestenone. Whereas 
hsd-1 fractions contained only very small amounts of dauer rescuing activity, 
the activity profile of hsd-1;daf-22 fractions was very similar to that of daf-22 
single mutant fractions, consistent with the hypothesis that production of dauer 
pheromone via DAF-22 downregulates DAF-12-ligand production (Figure 3.2).  
 
Figure 3.2 Bioactivity of hsd-1 metabolome fractions. Assessment of DAF-
12 ligand content using the in vitro luciferase assay in HEK-293T cells (left) 
and the in vivo daf-9(dh6) dauer rescue (right) with metabolome fractions from 
(Top) hsd-1, (Bottom) hsd-1;daf-22 
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However, comparative metabolomic analysis of hsd-1;daf-22 region I revealed 
production of large quantities of an additional steroid in hsd-1;daf-22 worms 
that is not produced in either daf-22 or daf-9;daf-12 mutants. Subsequent NMR 
spectroscopic analysis and comparison with a synthetic sample led to the 
identification of this hsd-1-specific steroid as (25S)-3-keto-cholestanoic acid 
("Δ0-DA", Figure 3.3). This fully saturated DA derivative is active in both the 
DAF-12 luciferase assay and the daf-9(dh6) dauer rescue assay, although its 
activity is lower than that of Δ1,7-and Δ7-DA (Figure 3.4).  Δ0-DA was absent in 
wild-type and daf-22 metabolomes, as determined by NMR spectroscopy and 
SIM-GC/MS. Analysis of hsd-1;daf-22 activity region II revealed a second hsd-
1-specific steroid, 3β-OH-Δ7-DA (Figure B.1). In hsd-1;daf-22 mutants, 3β-
OH-Δ7-DA is as abundant as the 3α-isomer, whereas 3β-OH-Δ7-DA is absent 
in both wild-type and daf-22 mutants. GC/MS analysis of hsd-1;daf-22 activity 
region I further revealed that amounts of both Δ1,7- and Δ7-DA are slightly 
reduced compared to daf-22 worms, whereby production of Δ7-DA may be 
more strongly affected than that of Δ1,7-DA (Figure 3.5). The identification of 
3β-OH-Δ7-DA and Δ0-DA in hsd-1;daf-22 mutant worms suggests that HSD-1 
may directly or indirectly participate in the biosynthesis of Δ7-DA and possibly 
Δ1,7-DA. HSD-1 has homology to mammalian 3β-hydroxysteroid 
dehydrogenases (Patel et al., 2008), which suggested its participation in 
introducing the 3-keto functionality in Δ4-DA. The absence of Δ4-DA and our 
identification of Δ0-DA as a shunt metabolite in hsd-1;daf-22 mutants may 
indicate that the hsd-1 pathway includes introduction of the 7,8-double bond in 
a saturated precursor, for example cholestanol, 3β-OH-Δ0-DA, or Δ0-DA, by an 
as-yet unknown enzyme, or that HSD-1 itself has 7-dehydrogenase activity. 
Notably, HSD-1 is expressed mainly in the neuron-like XXX cells, which lack 
expression of the Rieske-like oxygenase, DAF-36, required for biosynthesis of 
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most 7,8-unsaturated steroids in C. elegans (Wollam et al., 2011; Yoshiyama-
Yanagawa et al., 2011) . Taken together, our results suggest that HSD-1 
contributes to Δ7-DA biosynthesis in the XXX cells, but that Δ7-DA and Δ1,7-DA 
are produced via a separate pathway in other tissues. 
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Figure 3.3. Identification of Δ0-DA in active region I of hsd-1;daf-22. 
Sections of dqfCOSY spectra (600 MHz, CDCl3) used for identification of Δ
0-
DA. (a) HPLC-enriched fraction from hsd-1;daf-22 mutant. (b) Synthetic Δ0-
DA. Crosspeaks characteristic for Δ0-DA are boxed blue. 
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Figure 3.4. Biological acitivity of DAs identified in this study. (Left) 
Assessment of DAF-12 transcriptional activation in HEK-293T cells by the 
identified endogenous DAF-12-ligands. Luciferase assays were measured in 
triplicates and are shown with SD. (Right) Daf-9(dh6) dauer rescue with the 
identified endogenous DAF-12-ligands at 27 °C. For each data point there 
were two replicates with 100 animals per replicate, error bars SD. 
 
 
Figure 3.5. Endogenous concentrations of DAs. In vivo concentrations of 
Δ7-DA, Δ1,7-DA, and Δ0-DA derived from SIM-GC/MS-based quantification in 
wild-type (N2), daf-22, and steroid metabolism mutants (error bars, SD).  
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 Next, we investigated the DAF-12-ligand profile of mutants of the 
Rieske-like oxygenase, DAF-36 2-3. Mutants of daf-36, which is expressed 
primarily in the worm intestine, exhibit phenotypes consistent with strongly 
reduced DAF-12-ligand biosynthesis, such as a higher tendency to enter dauer 
(Rottiers et al., 2006). As in the case of hsd-1 mutants, we found daf-36 
mutant metabolome fractions to be largely inactive in the dauer rescue and 
luciferase assays, whereas daf-36;daf-22 double mutants produced significant 
dauer rescue activity in region I (Figure 3.7). GC/MS analysis revealed the 
presence of saturated Δ0-DA in this region (Figure B.2), which we had 
previously found only in hsd-1;daf-22 mutants. In contrast to hsd-1;daf-22 
mutants, Δ0-DA appears to be responsible for all of the activity observed in 
daf-36;daf-22 region I, since neither Δ7- nor Δ1,7-DA were detectable in this 
mutant. Total DAF-12-ligand amounts were much lower in the daf-36;daf-22 
metabolome than in hsd-1;daf-22 (Figure 3.5). These results indicate that the 
intestinally expressed 7,8-dehydrogenase, DAF-36, is required for Δ7- and 
Δ1,7-DA biosynthesis, whereas HSD-1 contributes to additional production of 
Δ7-unsaturated DAs in the XXX cells. It thus appears that the biosynthesis of 
Δ7- and Δ1,7-DA relies on partially redundant and tissue-specific pathways. 
 
Biosynthesis of Different Ligands is Differentially Regulated: 
 Whereas the hsd-1 mutation did not significantly affected the relative 
abundance of Δ1,7- and Δ7-DA, mutations of two other genes involved in DAF-
12-ligand biosynthesis and regulation, the short-chain dehydrogenase, dhs-16 
(Wollam et al., 2012), and the methyltransferase, strm-1 (Hannich et al., 2009), 
showed strongly altered ligand ratios. Analysis of the dhs-16;daf-22 
metabolome revealed greatly reduced production of Δ7-DA, whereas Δ1,7-DA 
levels were reduced only slightly (Figures 3.5 and B.3). These results indicate 
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that Δ1,7- and Δ7-DA may be derived from partially divergent biosynthetic 
pathways or that deletion of DHS-16 indirectly affects regulation of the Δ1,7-DA 
to Δ7-DA ratio. Only trace quantities of 3α-OH-Δ7-DA were detected in dhs-
16;daf-22 worms, indicating that production of both 3α-OH-Δ7-DA and Δ7-DA 
are DHS-16-dependent. Next, we characterized the DAF-12-ligand profile of 
strm-1 mutants (Figure B.3), which had previously been shown to produce 
elevated levels of DAF-12-ligands (Hannich et al., 2009). The 
methyltransferase, STRM-1, regulates DAF-12-ligand levels by converting 
cholesterol-derived intermediates of ligand biosynthesis into 4-methylated 
steroids, thereby rendering them unsuitable as ligand precursors (Hannich et 
al., 2009). NMR spectroscopy and SIM-GC/MS analyses revealed more than 
100-fold increased levels of Δ7-DA in strm-1 mutant metabolomes whereas 
Δ1,7-DA levels increased only about 7-fold compared to wild-type (Figure 3.5). 
These results provide further evidence for differential regulation of Δ1,7- and 
Δ7-DA biosynthesis. 
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Figure 3.6. Bioactivity of hsd-1 metabolome fractions. Assessment of 
DAF-12 ligand content using the in vitro luciferase assay in HEK-293T cells 
(left) and the in vivo daf-9(dh6) dauer rescue (right) with metabolome fractions 
from (Top) daf-36, (Bottom) daf-36;daf-22. 
 
Figure 3.7. Sterol Supplementation Experiments Reveal Differences in 
daf-40 from Other DA Synthetic Mutants. (A) Rescue of the Daf-c 
phenotypes of daf-40(hd100) mutants at 27°C with 33μM concentration of 
sterols. All compounds tested partially rescued, although only the DAs 
provided complete rescue (N=3, mean ± SEM). (Image Courtesy Josh 
Wollam). 
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Cytochrome P450 DAF-40 is involved in DA biosynthesis :  
 These results strengthened our original hypothesis that many of the 
enzymatic components of the DAF-12 ligand biosynthetic pathway still remain 
hidden. Therefore, to identify novel enzymes impacting DA biosynthesis, we 
conducted a genetic enhancer screen of the daf-36(k114) null allele, in which 
the ligand production is reduced but not abolished. The appearance of Mig 
(gonadal migration) and Daf-c (dauer constitutive) phenotypes at the normally 
permissive temperatures of 25°C were scored in previously reported genome-
wide RNAi screens (Figure B.4). The enhancement of these phenotypes 
reflected greater loss of ligand-mediated DAF-12 activation suggesting 
changes in the ligand-biosynthetic pathway. From these screens, several loci 
that affect DA production were identified, one of which was a cytochrome 
P450, T10B9.7/cyp-13a2, and was named daf-40 because of its role in C. 
elegans dauer formation.  
The discovery of the novel dafachronic acids as described in the 
previous chapter led us to investigate where exactly DAF-40 acts in DA 
biosynthesis. For this purpose, sterol supplementation experiments were 
carried out, wherein phenotypic rescue was scored with the exogenous 
addition of predicted intermediates in the pathway. Intermediates that are 
downstream or parallel to the daf-40 biosynthetic block should rescue whereas 
those lying upstream should not, a strategy used successfully to confirm the 
roles of daf-36, dhs-16 and daf-9 in DA pathways (Rottiers et al., 2006; 
Wollam et al., 2012; Motola et al., 2006). To our surprise, all sterol compounds 
partially rescued daf-40  Daf-c phenotypes, although only the DAs themselves 
fully rescued (Figure 3.10). Sterol rescue experiments carried out using 
double mutants with daf-36, dhs-16, and daf-9 showed the same rescue 
pattern as the single mutant, and not that of daf-40 (Figure B.5). This sterol 
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rescue profile differs significantly from most other known DA biosynthetic 
mutants, suggesting that daf-40 could be either upstream or parallel to known 
components, in a novel position or pathway. 
 
Comparative Metabolomics Identifies Daf-40 Dependent DAF-12 Ligands: 
  To further understand the role of DAF-40 in the ligand biosynthetic 
pathway we proceeded to analyze the changes in the sterol metabolome in 
daf-40 mutants. For this, we utilized a lipid fractionation approach. We 
hypothesized that fractionated lipid extracts from N2 wild-type animals should 
rescue daf-40 mutant phenotypes, whereas corresponding fractions obtained 
from daf-40 should not. Once again, we used the daf-9(dh6) rescue assay 
introduced in the previous chapter to identify fractions that contain DAF-12 
ligands. In the WT lipid fractions, the three active regions described previously, 
rescued daf-9(dh6) animals. When these fractions were examined for their 
ability to rescue daf-40(hd100), an additional set of fractions, Region 1 - 
Fractions 14-19, also rescued daf-40 but not daf-9 mutants (Figure 3.8), 
presumably containing earlier DA intermediates as seen with rescues with 
candidate sterols.  
 Continuing the investigation of the DA profile in daf-40 mutants we then 
prepared lipid extract fractions from daf-40;daf-22 double mutants, once again 
to obtain larger number of DA-producing worms in the absence of the dauer 
pheromone. Similar to results from wild-type animals, several fractions derived 
from daf-40:daf-22 animals rescued daf-9 mutants, likely containing DAs 
(Figure 3.8). These results suggest that daf-40 is not strictly required for DAF-
12 ligand production and that residual activity is sufficient for rescue. 
Surprisingly, whereas the Region 3 fractions from daf-22 efficiently rescued 
daf-9 and daf-40 mutants (Figure B.6), the corresponding fractions derived 
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from daf-40;daf-22 animals fully rescued daf-9 but could only partially rescue 
daf-40 mutants. This finding that the region 3 rescuing activity is dependent on 
DAF-9 suggests these fractions contain 26-carboxylic acid modifications 
catalyzed by DAF-9. Presumably, daf-9 mutants can directly use or efficiently 
convert compounds present in these daf-40 fractions to bypass dauer, 
whereas daf-40 animals cannot. A simple hypothesis is that DAF-40 acts on 
DA intermediates in these fractions that are products of DAF-9, or in a parallel 
pathway, but do not efficiently rescue dauer.     
 Consequently, we wanted to know how daf-40(hd100) mutants affect 
known sterol intermediates in the DA pathways and so their unfractionated 
sterol profile was examined by GC/MS/MS. Surprisingly little or no difference 
was seen in levels of known precursors of Δ7-DA synthesis, including 
cholesterol, 7-dehydrocholesterol, lathosterol or lathosterone (Figure 3.9). 
However, Δ7-DA levels were lower in daf-40 mutants relative to wild-type. 
Conversely, animals carrying an integrated daf-40::gfp overexpression 
construct contained elevated levels of Δ7-DA (Figure 3.9).  
 Since the levels of the measured intermediates did not change, these 
observations suggest that DAF-40 is involved in an alternative pathway of Δ7-
DA production and we proceeded to analyze the active metabolite fractions by 
NMR spectroscopy in order to identify the metabolites responsible for the 
phenotypic rescue. Proton NMR spectra of the Region 1 daf-40 rescuing 
metabolite fractions obtained from daf-40;daf-22 worms (fractions 12-14) 
confirmed the presence of predicted precursor molecules including cholesterol, 
7-dehydrocholesterol and lathosterol, in agreement with the initial sterol 
supplementation experiments (Figure 3.10). Due to extremely low abundance 
of the active components in Regions 2 and 3 these fractions had to be 
enriched by HPLC fractionation further to facilitate structure elucidation. While 
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the proton NMR spectra for HPLC-enriched active fractions from Region 2 
revealed the presence of Δ7-DA (Figure 3.10), the HPLC-enriched daf-40 
dependent Region 3 fractions contained 3α-hydroxy-Δ7-DA (Figure 3.10). This 
compound was detected in higher concentrations in daf-40 mutants compared 
to wild-type, as confirmed by GC/MS analysis (Figure 3.10). The identification 
of 3α-hydroxy-Δ7-DA as an endogenous DAF-12 ligand produced in C. 
elegans was described in the previous chapter, and this is specifically 
interesting due to the α-configuration of the hydroxyl group at the 3-position, 
reminiscent of mammalian bile acids. All previously characterized 3-
hydroxylated steroids in C. elegans contain the 3β-configuration, as does 
cholesterol. Daf-9 rescue experiments with 3α-hydroxy-Δ7-DAs revealed that 
3α-hydroxy-Δ7-DA provides much more effective rescue than the 3β-isomer, 
albeit at higher doses than Δ7-DA (Figure 3.10). 3α-hydroxy-Δ7-DA also 
rescued the Daf-c phenotypes of daf-40. Interestingly, it failed to effectively 
rescue daf-40;daf-9 double mutants, suggesting that both activities are 
required to convert this compound into a more potent ligand in vivo. Consistent 
with in vivo results, 3α-hydroxy-Δ7-DA activated DAF-12 transcriptional activity 
in cell culture, but required significantly higher concentrations than Δ7-DA itself 
(Figure 3.10). By contrast, 3α-hydroxy-Δ7-DA did not appreciably activate 
DAF-12. In addition, high concentrations of 3α-hydroxy-Δ7-DA, as well as the 
other DAs tested, rescued the reduced expression of the daf-12 target mir-241 
in both the daf-36 and daf-40 mutant backgrounds, although daf-40 mutants 
were not as efficiently rescued as daf-36 (Figure B.7). Altogether these results 
support our finding that 3α-hydroxy-Δ7-DA is a novel ligand for DAF-12, which, 
in these assays, is less potent than Δ7 or Δ1,7-DA and suggests that DAF-40 
acts on this compound to further convert it to a more potent ligand.  
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Figure 3.8. Rescue Experiments Suggest daf-40 Functions in a Novel 
Way to Influence DAF-12 Activity. (Top) Fractionated lipid extracts from daf-
40;daf-22 double mutants rescue the Daf-c phenotypes of daf-9(dh6) mutants 
at 20°C. The fraction number reflects increasing polarity of the elution gradient, 
with an estimated 150 ng/μL sterol concentration per fraction. The control ∆7-
dafachronic acid, as well as several fractions rescue the animals to various 
extents (green arrows). No discernible changes are found from the pattern 
seen in daf-22 rescues, demonstrating that DAs are still produced in the 
absence of daf-40 (N=3, mean ± SD). (Bottom) daf-40 dauer formation at 
27°C is also rescued by fractions from daf-40;daf-22 animals, as well as 
fractions 14-19 (Region 1). Rescue is not seen with Region 3 fractions 28-29, 
which efficiently rescue daf-9. These fractions potentially contain a precursor 
utilized by DAF-40 (N=3, mean ± SD). (Image Courtesy: Adam Antebi Lab).  
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Figure 3.9. daf-40 Mutant Animals are Deficient in Δ7-Dafachronic Acid. 
(A) GC/MS/MS sterol analysis of L3 stage N2 wild-type and daf-40(hd100) 
animals at 20°C reveals that although levels of the proposed DA precursors 
are not changed, significantly lower levels of Δ7-dafachronic acid are present 
in daf-40 mutants (N≥9 ± SEM; **P<0.005). (B) Δ7-dafachronic acid levels are 
reduced in daf-40 mutants and elevated in animals expressing an integrated 
dhIs839(daf-40::gfp) overexpression construct (N≥4 ± SEM; **P<0.005, 
*P<0.05). (Image Courtesy: Adam Antebi Lab). 
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Figure 3.10. NMR Analysis Reveals that DAF-40 Modulates Novel 
Dafachronic Acid Pathways. (A) Proton NMR spectra of the daf-40;daf-22 
Region 1 lipid fractions that rescue daf-40 mutants reveal that these fractions 
contain the proposed ∆7-DA precursors cholesterol, 7-dehydrocholesterol and 
lathosterol, consistent with previous sterol supplementation experiments. (B) 
NMR analysis of HPLC-enriched Region 3 fractions from daf-40;daf-22 
mutants, which contain potential DAF-40 activities, identified the presence of 
3α-hydroxy-∆7-DA. (C) Additional GC/MS/MS analyses of crude lipid extracts 
confirmed that daf-40 mutants contain elevated levels of 3-hydroxy-∆7-DA, 
suggesting it may act as a substrate of DAF-40 in a novel pathway of ∆7-DA 
production (N=9, ***P<0.0001). (Image Courtesy : Adam Antebi Lab) (D) Dose 
response experiments with 3α-hydroxy-∆7-DA. Only very high concentrations 
are able to rescue daf-40;daf-9 double mutants, consistent with daf-40 acting 
downstream or in parallel to daf-9 (N=3, mean ± SEM). (E) Analysis of DAF-12 
transcriptional activity in response to ligand activation in HEK293T cells. 
Provision of ∆7-DA or 3α-hydroxy-∆7-DA activates the transcription of 
luciferase driven by the mir-84 promoter (N=3, mean ± SEM).  
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DAF-40 Acts as a 3-α-Hydroxysterol Oxidase:   
Based on our identification of 3α-hydroxy-Δ7-DA in the sterol fractions 
that showed daf-40 dependence, we hypothesized that DAF-40 contains 3-
hydroxysteroid dehydrogenase activity, converting 3α-hydroxy-Δ7-DA to the 3-
keto form. This would explain the accumulation of 3α-hydroxy-Δ7-DA and 
reduction of levels of Δ7-DA in daf-40 mutants. To determine the biochemical 
activity of DAF-40, we expressed the gene in cultured cells and assayed 
activities from isolated microsomes. Indeed, we observed that 3α-hydroxy-Δ7-
DA was converted to Δ7-DA in the presence of DAF-40 (Figure 3.11). We 
therefore conclude that DAF-40 has 3-hydroxysteroid dehydrogenase activity, 
transforming 3α-hydroxyl substrates to their corresponding 3-ketone products. 
 
 
Figure 3.11.  DAF-40 Acts as a 3-α-Hydroxysterol Oxidase. Enzyme assays 
reveal that DAF-40 acts as a 3-hydroxysteroid dehydrogenase to produce Δ7-
DA from 3α-hydroxy-Δ7-DA (N=2, mean ± range) (Image Courtesy Josh 
Wollam). 
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Conclusions and Discussion: 
Although it is well established that DAF-12 ligands are ultimately 
derived from dietary cholesterol, identification of Δ1,7-DA and 3α-OH-Δ7-DA, 
and the absence of Δ4-DA, as described in the previous chapter necessitated 
revision of DAF-12-ligand biosynthesis models. In this chapter, the author 
described the utilization of comparative metabolomics approaches towards the 
elucidation of steroid metabolism in C. elegans. These results indicate that 
DAF-36 as well as HSD-1 participate in the biosynthesis of Δ7-DA and possibly 
Δ1,7-DA, whereas previously, HSD-1 had been assumed to function in Δ4-DA 
biosynthesis. The finding that mutation of dhs-16 affects Δ7-DA much more 
strongly than Δ1,7-DA production suggests that, introduction of the 3-keto 
moiety in Δ1,7-DA may involve a different enzyme. Therefore, it appears that 
different DAF-12-ligands are produced via partially divergent biosynthetic 
pathways, which is also supported by the finding that in strm-1 mutants Δ7-DA 
production is increased to a much greater extent than that of Δ1,7-DA. 
C. elegans offers a unique opportunity to study the role of tissue-
specific NHR ligand biosynthesis for endocrine signaling in a simple model 
system. DAF-12-ligand biosynthetic enzymes link conserved insulin/IGF and 
TGF-β signaling to transcriptional regulation by DAF-12 (Wollam et al., 2012). 
The biosynthesis of multiple DAF-12-ligands via partially divergent pathways 
suggests that different ligands may serve different functions (Figure 3.12) 
(Arda et al., 2010). Notably, a recent study showed that DAF-12-ligand 
production in different worm tissues is interdependent, indicating that some 
DAF-12-ligands or ligand derivatives function as signaling molecules that 
trigger additional ligand production in tissues distal to the original site of ligand 
biosynthesis (Schaedel et al., 2012). The two neuron-like XXX cells appear to 
function as central regulators of organism-wide commitment to either 
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reproductive development or dauer (Gerisch and Antebi, 2004; Schaedel et al., 
2012). Under favorable conditions, DAF-12-ligands produced in the XXX cells 
are thought to trigger abundant additional ligand biosynthesis in the 
hypodermis, locking in organism-wide commitment to reproductive adult 
development. Since the XXX cells are the primary sites of HSD-1 expression 
(Dumas et al., 2010; Patel et al., 2008), our finding that HSD-1 may contribute 
to Δ7-DA biosynthesis supports a model in which XXX-produced Δ7-DA (or 
derived 3α-OH-Δ7-DA) triggers biosynthesis of large quantities of additional Δ7-
DA and Δ1,7-DA via daf-36, dhs-16, and hypodermal daf-9 (Figure 3.12). 
Taken together, our identification of Δ1,7-DA, 3α-OH-Δ7-DA, and Δ0-DA as well 
as the differential production of these compounds in different mutant 
background indicates that several tissue specific components of the DAF-12-
ligand biosynthetic pathway remain to be identified.  
Subsequently, in a collaborative analysis of C. elegans sterol 
metabolites, utilizing a multidisciplinary approach the cytochrome P450 DAF-
40 was characterized as a component of a novel branch of DAF-12 ligand 
biosynthesis influencing development and lifespan. Daf-40 exhibits several 
unique features suggestive of a role in parallel to the previously proposed DA 
biosynthetic pathways. In contrast to most genes involved in DA production, 
daf-40 mutant phenotypes were partially rescued by all proposed DA 
precursors, including cholesterol. In this regard it does not easily fit into the 
predicted model of DA synthesis, and suggests a novel role. Sterol profile 
analysis of daf-40 mutants revealed significantly less Δ7-DA, despite having 
normal levels of precursors, while animals overexpressing DAF-40 displayed 
elevated Δ7-DA levels. Second, daf-40;daf-22 lipid extract fractions were able 
to rescue daf-9 null mutants but not daf-40 animals, whereas fractions from 
wild-type or daf-22 animals rescued both mutants. Rescuing activities in these 
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fractions included the novel 3α-OH-Δ7-DA, suggesting this compound may be 
a DAF-40 substrate. Accordingly, daf-40 mutants accumulate 3α-OH-Δ7-DA. 
Finally, biochemical analysis of DAF-40 activity in cell culture demonstrates 
that it is able to convert 3α-OH-Δ7-DA to Δ7-DA and is one of the many missing 
components in the DA-biosynthesis pathway in C. elegans and probably other 
nematodes. It is also likely that DAF-40 has additional substrates and activities 
and future biochemical studies will reveal its specificity or promiscuity.  
With the results described in Chapter 2 and Chapter 3, one can start 
hypothesizing about the roles that the different DAs play in C. elegans 
development and lifespan. While our initial characterization of these DAs has 
not uncovered strict functional differences, the difference in biological activity 
between these ligands is apparent (Figure B.8). It remains possible that 3α-
OH-Δ7-DA may influence sterol transport, act as an inhibitor, or be an alternate 
ligand mediating specific events. Further investigation into gene expression 
profiles of animals after treatment with these DAs should provide insight into 
functional differences, if they exist. 
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Figure 3.12.  Model for biosynthesis of DAF-12-ligands that regulate 
development and lifespan (Schaedel et al., 2012; Yamawaki et al., 2010). 
Enzymes in the XXX cells downstream of insulin and TGF-β signaling produce 
some Δ7-DA, which triggers additional biosynthesis of DAF-12 ligands via 
upregulation of DAF-9 expression in the hypodermis, dependent on intestinally 
expressed DAF-36 and possibly other tissues. The lifespan-increasing effects 
of DAF-12 ligands depend on germ cell removal (Yamawaki et al., 2010). 
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CHAPTER 4 
 
USING DIFFERENTIAL ANALYSIS BY 2D-NMR SPECTROSCOPY (DANS) 
TO INVESTIGATE TRYPTOPHAN METABOLISM IN C.ELEGANS: 
IDENTIFICATION OF DEATH FLUORESCENCE AND INVESTIGATION OF 
THE KYNURENINE PATHWAY 
 
Introduction: 
  As introduced earlier, the simplicity of the model organism C. elegans 
provides unique opportunities to study biological pathways of metazoans. 
Ongoing C. elegans research continues to reveal intriguing phenotypes. One 
such example is the presence and function of “gut granules”, located 
abundantly in the intestinal cells of nematodes across the suborder Rhabditina 
(Chitwood and Chitwood, 1950). Because gut granules share functional 
similarities with lysosomes in their capacity for endocytosis and their acidic 
interior (Hermann et al., 2005; Clokey and Jacobsen, 1986) they are generally 
referred to as lysosome-related-organelles (LROs) (Hermann et al., 2005; 
Bernabucci et al., 2012), with similarity to the pigment containing 
melanosomes in mammals and eye pigment granules in Drosophila (Raposo 
and Marks, 2007). Notably, under ultraviolet light, gut granules emit blue 
fluorescence, with maximal intensity at 340/430 nm (λex/λem) (Figure 4.1). 
 Lipofuscin is believed to accumulate with age in mammalian cells 
(Jung et al., 2007) and has frequently been used as biomarker for aging 
(Brunk et al., 2002; Jung et al., 2007, Terman et al., 1998). Consistent with this 
theory, blue fluorescence levels increase gradually with age in worm 
population cohorts (Garigan et al., 2002; Gerstbrein et al., 2005), but the 
presence of lipofuscin has not been verified in C. elegans. The composition of 
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lipofuscin is usually poorly defined and assumed to be somewhat variable, 
although autofluorescent properties are generally listed as its distinguishing 
characteristic (Jung et al., 2007). When excited by in vitro UV light, so-called 
lipofuscin emits blue fluorescent light, potentially due to the presence of Schiff 
bases (Fletcher et al., 1973; Klass et al., 1977), in addition, excitation of 
lipofuscin by UV in vivo results in peak fluorescence in the 540-640 nm 
(orange-yellow) range (Eldred et al., 1982). While these observations point 
towards lipofuscin as the fluorescent material in C. elegans intestine, 
biochemical composition of the C. elegans blue fluorescence has not been 
carried out.  
 
Figure 4.1. Gut granule fluorescence in C. elegans. Fluorescent gut 
granules (arrow heads) in intestinal cells of healthy, young adult C. elegans. 
Bottom, blue fluorescence observed through a DAPI filter. Top, brightfield and 
blue fluorescence images overlaid (Image courtesy – Cassandra Coburn).  
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 A parallel and less popular idea about the origin of the blue 
fluorescence has been proposed from studies of C. elegans mutants with 
altered autofluorescence properties. Flu mutants have abnormal gut granule 
autofluorescence color and intensity (Siddiqui and Babu, 1980), and the, until 
recently unmapped, FLU genes have been hypothesized to function in 
tryptophan catabolism (Siddiqui and Babu, 1980). Metabolomics analysis of 
these mutants with respect to altered tryptophan catabolism has not been 
carried out.  
 In this study, the author describes how using Differential Analysis by 
2D-NMR Spectroscopy the structural identity of the blue fluorescence in C. 
elegans was discovered and how this technique can be utilized to elucidate 
the tryptophan degradation pathway (aka kynurenine pathway) in C. elegans.   
 
Blue fluorescence increases with death not stress:  
This work was done in collaboration with Cassandra Coburn in Prof. 
David Gems’ Lab at University College London, London.  
Raised oxygen levels (40% O2) increases lipofuscin levels in human 
fibroblasts (Terman et al., 1998) and so in order to investigate whether the 
blue fluorescence in C. elegans was indeed due to accumulation of lipofuscin 
in the gut granules, worms were exposed to normobaric hypoxia (90% O2), 
and elevated iron levels. Both treatments significantly raised protein oxidative 
damage, but neither increased blue fluorescence levels (Figure 4.2). This 
implies that C. elegans blue fluorescence is not a result of oxidative damage, 
suggesting that it is not lipofuscin. 
Comparable to lipofuscin in mammals, mean fluorescence levels 
increase slowly with age in C. elegans population cohorts (Eldred et al., 1982; 
Garrigan et al., 2002), but population mean data does not address 
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inhomogeneity in the fluorescence of individual worms. This concern is 
addressed in a recent publication (Hermann et al., 2005) where it is reported 
that when individually analyzed, significant increase in C. elegans blue 
fluorescence levels is only seen in animals closer to death. To test this directly 
for the purpose of the present study, fluorescence levels of individually 
cultured, wild-type C. elegans in situ on nematode growth medium (NGM) agar 
plates were analyzed at intervals through their entire lifetime using a DAPI 
filter (λex/λem = 340/430 nm). Reduction of movement was considered the 
indicator of approaching of death and time-lapse imaging was used to capture 
fluorescence changes during death. This revealed that fluorescence levels in 
singular animals did not change significantly until immediately prior to death. 
Then, coinciding with the cessation of movement (i.e., death) a sudden and 
dramatic ~400% increase occurs in the fluorescence level (Figure 4.3). This 
increase begins at ~2 h prior to death, and then fades by ~6 h after death 
(Figure 4.3).  
Blue fluorescent bursts are not specific to death from old age but could 
also be induced by killing younger worms, either using a heated worm pick on 
the agar adjacent to the worm or by freeze-thaw or low pH (Figure 4.4). This 
observation was also conserved in the nematodes C. briggsae and 
Pristionchus pacificus (Figure 4.4). Additionally, in both aged and killed 
worms, the distribution of fluorescence changed from punctate to diffuse 
during death, and eventually spread from the intestine to other tissues (Figure 
4.4). This phenomenon was named Death Fluorescence (DF).  
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Figure 4.2. Molecular damage does not increase blue fluorescence. 
Hyperoxia (5-d exposure) and free iron (1-d exposure) increase protein 
oxidation, but not blue fluorescence. (Data courtesy Cassandra Coburn) 
 
  
Figure 4.3. Blue fluorescence increases with death. Mean levels of 
fluorescence relative to time of death (black line), ± SD (blue lines) (Data 
courtesy Cassandra Coburn). 
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Figure 4.4. Visualization of DF. DF in young adult hermaphrodite killed with a 
heated wire. During DF the pattern of fluorescence changes from punctate to 
diffuse. A and P, anterior and posterior ends of intestine. Arrowheads, spread 
of DF from intestine to other tissues. Time, with respect to death. (Data 
courtesy Cassandra Coburn)  
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Comparative metabolomics reveals the chemical identity of death 
fluorescence (DF):  
Once it was established that blue death fluorescence in C. elegans 
(being referred to as Death Fluorescence or DF for the rest of this chapter) is 
not generated by oxidative damage and is correlated with death and not aging, 
it seemed unlikely that lipofuscin was responsible. Therefore, we investigated 
the chemical identity of the blue fluorophore responsible for DF using 
Differential Analysis by 2D NMR Spectroscopy (DANS). As previously 
described, this comparative metabolomics approach allows identification of 
metabolites whose production is dependent on a specific genetic background 
without extensive chromatographic fractionation. For this comparison, we 
chose to compare the metabolome of wild-type C. elegans with that of the glo-
1 (zu437) (gut granule loss 1) mutant strain which are deficient of gut granules 
(Hermann et al., 2005). glo-1 animals showed significantly lower blue 
fluorescence both during life or death due to aging or thermal injury, 
suggesting that gut granule formation and DF are connected (Figure 4.5).  
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Figure 4.5. glo-1 animals do not show gut granules or DF.  glo-1(zu437) 
animals do not show an increase in blue fluorescence during aging (A) nor DF 
upon killing (B), making them a useful negative control for establishing the 
chemical source of gut granule fluorescence and DF.  (Data courtesy 
Cassandra Coburn) 
 
 We first confirmed that blue fluorescence is present in whole-worm 
sonicates of wild-type animals, whereas sonicates of glo-1(zu437) mutants 
contained no blue fluorescence. After several purification steps, blue 
fluorescence remained present in the supernatant of wild-type worm 
homogenates (Figure C.2). The fluorophore also remained after protein 
precipitation through addition of 100% ethanol in the ratio 1:9 (Fig 3B), 
indicating that that the fluorophore is not proteinaceous. Gradient high 
performance liquid chromatography (HPLC) was then used to identify peaks at 
ex/em 340/430 nm. Four peaks were present in the N2 samples but not in glo-
1(zu437) or water controls (Figure C.3). The most intense peak eluted from 
the column within the polar-mobile phase, indicating that it had highly polar 
functional groups while the others were relatively less polar. 
   We then proceeded to acquire dqfCOSY spectra of the sonicates of 
wild-type and glo-1(zu437) worms. Comparison of the wild-type and glo-
1(zu437) spectra showed significant differences in both the aliphatic and 
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aromatic regions (Figures 4.6 - 4.9). These differences resulted from the 
presence of several groups of strong signals in the wild-type spectra that were 
absent or much attenuated in the glo-1(zu437) spectra. Detailed analysis of 
the fine structures of the differential signals indicated that the compounds 
absent in glo-1(zu437) mutants include three anthranilic acid moieties, an N-
substituted indole, as well as four β-glucosyl units (Figures 4.6 - 4.9). The 
chemical shift values of the anomeric protons in the four β-glucosyl moieties 
suggested that two of these are attached to anthranilic acid moieties forming 
two glucosyl esters, whereas the two remaining glucose units appeared to be 
part of N-glucosyl indoles. Furthermore, a characteristic downfield shift and 
additional J-splitting (Figures 4.6 - 4.9) of the protons in position 3 of two of 
the four glucose moieties indicated that anthranilic acid glucosyl ester (angl#1, 
Figures 4.6 - 4.9) and N-glucosyl indole (iglu#1) were both accompanied by 
the corresponding 3'-phosphorylated compounds (angl#2 and iglu#2) (Figure 
4.9). These structural assignments were confirmed via high-resolution mass 
spectrometry and synthesis of authentic samples of anthranilic acid glucosyl 
ester and N-glucosylindole (Appendix C) (Roell and Rösler et al., 2011, 
Messaoudi et al., 2004).  
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Figure 4.6. NMR-based comparative metabolomics (DANS) applied to C. 
elegans wild type (N2) and glo-1(zu437). Comparison of the aromatic 
regions of dqfCOSY 2D NMR spectra of wild type (N2, upper panel) and glo-
1(zu437) (lower panel) sonicates reveals several groups of signals that are 
strongly downregulated in the glo-1(zu437) spectrum. These correspond to 
indole glucosides (black boxes) and fluorescent anthranilic acid derivatives 
(blue boxes). 
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Figure 4.7. Biochemical identification of DF constituents - aliphatic 
region Comparison of 3.4-4.2 ppm region of the dqfCOSY spectrum (600 
MHz, methanol-d4) of N2 worm sonicates (top) and glo-1 mutants (bottom) 
show cross-peaks representing several glucose moieties (black boxes). 
Crosspeaks at f2 = 4.12 ppm correspond to proton 3-H in angl#2 and show 
additional J-splitting due to coupling with 31P of the adjacent phosphate group 
(double bordered boxes). 
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Figure 4.8. Biochemical identification of DF constituents – anomeric 
protons Section of the dqfCOSY spectrum (600 MHz, methanol-d4) of N2 
worm sonicates (top) and glo-1 worm sonicates (bottom) showing crosspeaks 
for the anomeric protons of four glucose units. Two of these (red boxes) 
belong to the indole glucosides (iglu #1, iglu#2) and the other two (blue boxes) 
are part of the anthranilic acid glucosides (angl#1, angl#2) (Figure 4.9). 
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Figure 4.9. DANS analysis reveals glo-1 dependent small molecules. 
Structures of C. elegans metabolites identified via DANS that are strongly 
downregulated in glo-1(zu437). 
 
Metabolite fractions obtained from N2 worm pellets grown in liquid 
cultures as described in Chapter 1 and 2 when exposed under UV showed 
blue fluorescence (Figure C.4). Proton NMR analysis of these fractions also 
confirmed that fluorescent fractions contained anthranilic acid moieties 
whereas glucosylated indoles were found in the non-fluorescent fractions 
(Figure C.5).  
 
DF Arises from tryptophan via the kynurenine pathway:  
The indole glucosides, iglu#1 and iglu#2, previously unreported in 
animals, did not emit blue fluorescence. AA is formed during catabolism of L-
tryptophan via the kynurenine pathway (Figure 4.10) and has previously been 
observed in C. elegans (Rongvaux et al., 2003; van der Goot et al., 2012), but 
neither angl#1 nor angl#2 have previously been reported in animals. 
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Anthranilic acid (AA) derivatives show characteristic fluorescence at ex/em 
340/430 nm (Nakken et al., 1963), and their absence in the non-fluorescent 
sonicates of glo-1(zu437) mutant worms indicates that these compounds are 
responsible for the blue fluorescence observed in wild-type animals.  
 
 
 
Figure 4.10. Kynurenine pathway in C. elegans. C. elegans genes known to 
be orthologous to mammalian genes in this pathway are shown in brackets 
and bold.  
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Figure 4.11. Fluorescence spectra for angl#1 (2 mM) and worm blue 
fluorescence are highly similar. Also shown is fluorescence of unconjugated 
anthranilic acid (2 mM). Data courtesy Filip Matthijssens (Bart Braeckman Lab, 
University of Ghent) 
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Moreover fluorescence spectra for angl#1 and worm blue fluorescence 
were identical (Figure 4.11). Additionally, the HPLC retention times of the 
identified AA derivatives match those of the fluorescent peaks detected in the 
initial HPLC analysis of the wild-type sonicates. Together, these data provide 
the structural evidence for the identification of anthranilic acid derivatives as 
fluorophores responsible for DF in nematodes. 
To further verify this result, we used a genetic approach. The enzyme 
responsible for the first step in the conversion of Trp to AA is tryptophan 2,3-
dioxygenase (TDO) encoded in C. elegans putatively by the gene tdo-2 
(C28H8.11). (Rongvaux, 2003; van der Goot, 2012). Treatment with tdo-2 
RNAi greatly reduced gut granule blue fluorescence and DF (freeze thaw) 
(Figure C.6). We further tested exogenous AA is sufficient to cause blue gut 
granule fluorescence. Indeed incubation of tdo-2-RNAi treated worms with 5 
mM AA restored gut granule fluorescence to wild-type level (Figure C.6). We 
therefore concluded that gut granule fluorescence and DF emanate from AA.  
 
Preliminary DANS analysis of the Flu mutants: 
The identification of AA derivatives as DF fluorophores suggested that 
knowledge of tryptophan metabolism in C. elegans is incomplete. In particular, 
we were interested in the yet undetermined role of Flu mutants in the 
kynurenine pathway, one of the most highly conserved pathways across 
species. As noted earlier, several metabolites of this pathway have been 
implicated in various metabolic and degenerative disorders in mammals 
(Figure 4.10) and yet the first detailed investigation on the kynurenine 
pathway in C. elegans was reported only in 2012 (van der Goot et al., 2012). 
We therefore used DANS methodology to compare dqfCOSY spectra of 
metabolite extracts obtained from wild-type animals and from the four flu 
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mutants previously described. Our preliminary objective was to develop 
hypotheses about these genes' biosynthetic roles, based on observing 
changes in the global metabolomes of these mutants, which to date have not 
been cloned. 
Comparison of wild-type and flu-1 spectra showed significant 
differences in the aromatic region. Flu-1 mutants have been reported to 
demonstrate significantly reduced kynurenine-3-hydroxylase activity (Siddiqui 
and Babu, 1980). Kynurenine 3-hydroxylase is responsible for the conversion 
of kynurenine into 3-hydroxy kynurenine  or anthranilic acid to its 3-hydroxy 
counterpart (Babu et al., 1974). Therefore, flu-1 mutants should have reduced 
levels of 3-hydroxy kynurenine (3-OH-Kyn) or 3-hydroxy anthranilic acid (3-
OH-AA) and increased levels of l-kynurenine (Kyn) and AA. These changes 
are indeed evident when the flu-1 and wild-type dqfCOSY spectra are 
analysed in a greater detail (Figure 4.12). 
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Figure 4.12. NMR-based comparative metabolomics (DANS) 
applied to C. elegans wild type (N2)  and flu-1. Comparison of the aromatic 
regions of dqfCOSY 2D NMR spectra of wild type (N2, upper panel) and flu-1 
(lower panel) sonicates reveals several groups of signals that are either 
strongly downregulated in the flu-1 spectrum (black boxes), or upregulated in 
the flu-1(red boxes) or remain unchanged (blue boxes). 
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Flu-2 putatively encodes for the kynureninase enzyme which also uses 
kynurenine as a substrate converting it to anthranilic acid. Similarly, it can 
convert 3-OH-Kyn to 3-OH-AA. Our 2D-NMR spectroscopy based comparison 
of the flu-2 metabolome to the wild-type metabolome, shows a striking 
difference. All of the cross peaks, earlier characterized to be derived from 
antranilic acid moieties were either absent or significantly downregulated. This 
suggests that the flu-2 mutants contain a null mutation of the kynureninase 
gene and therefore has a blocked anthranilic acid production and 
conseqeuently an abnormal autofluorescence. (Figure 4.13). There are other 
differences between the two metabolomes but these differences have not 
been investigated to a greater detail and will be the subject of future studies.  
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Figure 4.13. NMR-based comparative metabolomics (DANS) applied to C. 
elegans wild type (N2) and flu-2. Comparison of the aromatic regions of 
dqfCOSY 2D NMR spectra of wild type (N2, upper panel) and flu-2 (lower 
panel) sonicates reveals several groups of signals that are either strongly 
downregulated in the flu-2 spectrum (black boxes), or upregulated in the flu-
2(red boxes) or remain unchanged (blue boxes).  
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RNAi or mutation of flu-2 (putative kynureninase) also reduced DF, 
while inactivating kynurenine 3-monooxygenase by RNAi or flu-1 mutation 
raised DF, as expected according to the kynurenine pathway (Figure 4.14). 
These results along with our spectroscopic data support the putative 
enzymatic functions assigned to FLU-1 and FLU-2 and encourages further 
study on the tryptophan degradation pathway using the DANS methodology.  
 
 
Figure 4.14. Kynurenine pathway genes affect DF levels. Effects of RNAi of 
kynurenine pathway genes on DF. Worms were killed by freeze thaw, and 
fluorescence measured in a plate reader (Appendix C) (Image Courtesy : 
Cassandra Coburn). 
 
While flu-1 and flu-2 have been assigned a putative function in the tryptophan 
degradation pathway, the other two members of the Flu mutant family have not 
been connected to any phenotype or function except their altered 
fluorescence. We have started to analyze the differences in the metabolomes 
of flu-3 and flu-4 mutants from wild-type C. elegans (Figures C.7 and C.8) 
specifically investigating changes in the production of tryptophan catabolites. 
Comparison of the wild-type and flu-3 spectra reveals one distinct difference 
between the two metabolome. The signal at 6.53 and 7.82 ppm is strictly 
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present in N2 and absent in flu-3. Preliminary analyses of this crosspeak and 
comparison with commercial standards of metabolites from the Kynurenine 
Pathway suggest that this cross peak is derived from an anthranilic acid 
moiety. But interestingly other anthranilic acid moieties such as angl#1 and 
angl#2 are present in flu-3 suggesting a possible perturbation in the tryptophan 
degradation pathway and further analyses will reveal connections between 
these other differential cross peaks.  but these differences have not been 
analyzed in greater detail.  
Similar preliminary analysis of flu-4 spectra also show minor differences 
in the aromatic region of the metabolomes, although none among the AA 
derivatives suggesting that, flu-4 mutations do not perturb any of the known 
genes in the tryptophan catabolism and any changes arising in its 
autofluorescence is possibly a consequence of perturbations in another 
pathway.  
Together these results show that our comparative metabolomics 
approach is extremely powerful for investigating the kynurenine pathway in C. 
elegans and based on these preliminary studies we can proceed towards fully 
characterizing all known and putative mutants implicated in the tryptophan 
degradation pathway to obtain a complete understanding of the downstream 
metabolites produced i.e. understanding gene function by looking at the 
metabolite profiles. The knowledge of these intermediates will not only help 
our understanding of tryptophan degradation but also complement our efforts 
to identify a novel ligand for the C. elegans aryl hydrocarbon receptor, ahr-1. 
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Conclusions and Discussion: 
In this chapter, the author shows the utilization of Differential Analysis 
by 2D-NMR Spectroscopy technique to identify the chemical moieties involved 
in the striking blue fluorescence produced within the gut granules in 
nematodes. Coupled with biochemical and genetic techniques (Cassandra 
Coburn, University College London) and Fluorescence measurements (Filip 
Matthijssens, Bart Braeckman Lab, University of Ghent), this work explains 
how this blue gut granule fluorescence is actually associated with death and 
not aging, and thus defines a new phenomenon, that of “death fluorescence”. 
While previously it was proposed that the origin of this fluorescence is 
lipofuscin, a heterogenous protein degradation product mix, this study provides 
unambiguous spectroscopic evidence to confirm the role of tryptophan 
derived, anthranilic acid derivatives as the blue fluorophore.  
The identification of these anthranilic acid derivatives was made 
possible by comparing metabolomes of WT and glo-1(zu437), a mutant strain 
defective in the biogenesis of gut granules and consequently deficient in gut 
granule fluorescence. The anthranilic acid glucosyl ester angl#1 and its 
corresponding 3-O-phosphorylated derivative angl#2 account for both death 
and gut granule-associated fluorescence. glo-1 mutants lack both forms of 
fluorescence and AA derivatives, and inhibition of the kynurenine pathway 
blocks both forms of fluorescence, establishing that this blue fluorescence is 
not lipofuscin. Whether lipofuscin accumulation occurs during aging in C. 
elegans remains an open question. However, our finding that blue 
fluorescence is not lipofuscin removes one reason for believing that aging in C. 
elegans is caused by accumulation of stochastic molecular damage. The 
kynurenine pathway that generates gut granule and DF is also involved in 
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mammalian neurodegeneration, and has recently been shown to regulate 
protein folding homeostasis in C. elegans (van der Goot et al., 2012). 
One can explore several possibilities to explore the possibilities of roles 
of kynurenines in C. elegans. It is possible that AA derivatives may have some 
protective function. There is evidence that the kynurenine pathway is involved 
in immunity and tumuorogenesis (Opitz et al., 2011). AA can inhibit growth of 
bacterial pathogens (Sasaki et al., 2012) and 3-hydroxyanthranilic acid can 
induce cell death in lymphocytes (Piscianz et al., 2011). Alternatively the 
kynurenines may contribute to organismal death in some manner that is not 
self-evident. It has been found that in patients suffering from stroke, 
Huntington’s disease chronic brain injury and depression, amongst other 
diseases, an increased AA to 3-HA ratio can be seen.  
For this reason, we have started investigating the kynurenine pathway 
using DANS methodology and while comparison of the N2 metabolome with 
that of flu-1 and flu-2 confirms the putative role of these genes in the 
kynurenine pathway, similar comparison of the N2 and flu-3 metabolome 
provides preliminary evidence that there may exist other novel regulators of 
the tryptophan degradation pathway that has not been reported previously and 
this work will be continued in the Schroeder Lab. 
 Another direct consequence of this work is to look into the role of these 
tryptophan catabolites in other C. elegans pathways, e.g. as ligands of the 
transcription factor AHR-1(Opitz et al., 2011) or maybe as signaling molecules 
involved in protection against bacterial toxicity (Dan Kalman Lab, personal 
communication). Recent studies show that kynurenine is a putative 
endogenous ligand of AHR-1 in mammalian tissues (Opitz et al., 2011). There 
are numerous other studies which implicate several other tryptophan 
derivatives as endogenous activators of this ligand dependent transcription 
 126 
factor and further study of the tryptophan degradation pathway in C. elegans 
will surely allow us to understand: 1) what are the endogenous ligands for C. 
elegans aryl hydrocarbon receptor encoded by ahr-1, 2) does the flu mutants 
and other kynurenine pathway mutants form a biosynthetic block to the 
production of these ligands and 3) do these same molecules bind the 
mammalian AhR ?  
Other unanswered questions that remain is the need for glycosylation of 
the anthranilic acid moieties as well as the biological significance of gut 
granules. It has been previously reported that glycosylation is a technique that 
C. elegans uses to make toxic substances within its body more polar and 
therefore easily excretable (Bommarius B, et al., 2012; Stupp et al., 2011). 
While it does not seem likely in the case of AA derivatives, since they are 
largely confined within the animal, the reasons for glycosylation of the AA 
moieties and subsequent phosphorylation, still needs to be investigated. 
Similarly, while this work does provide a concrete evidence for the structural 
identity of death fluorescence, which originates in the gut granules, the actual 
biological significance of the gut granules still remains a mystery and future 
analysis of the glo family of mutants should reveal exciting insights to this end.  
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CHAPTER 5 
 
CONCLUSIONS AND OUTLOOK 
 
Conclusions and impact of this work 
 While quantitative measurement of the impact of any scientific work 
requires multiple factors to be considered and is often corrupted with specific 
biases, one interesting way of evaluating scientific results could be by 
weighing not just the number of questions answered but also the number of 
new questions unearthed as a consequence of the investigation. Applying this 
metric to evaluate this study, one can come up with a plethora of questions 
regarding animal metabolism in general, all based on the results generated by 
this study.  
 The most important outcome of this work is the demonstration of a 
largely unbiased (by preconceptions about ligand structures) approach for the 
identification of endogenous small molecule ligands for NHRs. This is 
significant because NHRs, both historically and continually, have been 
important targets for therapeutic development (Shi, 2007) due to the possibility 
of perturbing their activity by small molecules. A systematic, unbiased 
approach to identify ligands and their biosynthetic machinery providing will 
reveal multiple new nodes that can be perturbed or fine-tuned for therapeutic 
purposes. Only 50% of mammalian NHRs have known ligands, and of these 
50%, a majority have subsequently become therapeutic targets (Shi, 2007). 
While our understanding of the roles that NHRs play has continuously 
improved, the same cannot be said about our knowledge of their endogenous 
ligands. This work provides a novel approach to bridge this gap.  
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       Specifically, this study has identified key components of the steroid 
biosynthetic machinery in C. elegans that are fascinating because of the 
unexpected nature of some of their structural features. The discovery of a ∆1 
steroid in C. elegans is the first example for such steroids in animals. This is 
especially interesting because of the already known significance of the ∆1 
double bond in synthetic ligands of mammalian NHRs (Counsell and Klimstra, 
1962; Goulding and Flower, 2001) and calls for reinvestigation of mammalian 
NHR ligand pathways for the presence of this structural modification. In 
addition it will be of great interest to find the C. elegans enzyme that 
incorporates this double bond in the steroid A-ring, an enzymatic function 
previously unrecognized in animals. Questions such as tissue specificity and 
species specificity of this enzyme can then be asked.  
 Similarly, the identification of a 3-α-hydroxy steroid in C. elegans, a 
sterol auxotroph that utilizes exogenous cholesterol and other 3-β-hydroxy 
sterols as its primary sterol source, directs towards the existence of another 
previously unrecognized, steroid-metabolizing enzyme in C. elegans, and 
perhaps other metazoans. The subsequent characterization of the 
CYP450/DAF-40 as a regio-specific enzyme carrying out oxidation (and 
putatively other functions) at the 3 position of steroids underlines our original 
hypothesis that the identification of newer small molecules will lead to the 
identification of other novel components in pathway regulating the NHR DAF-
12.  
 Together, these results will revitalize the interest of the C. elegans 
community in understanding NHR function and reinforce the idea that minute 
changes in the structure of a small-molecule can significantly change its 
overall function and subsequent physiological responses. We now have to ask 
whether there is a specific function of the additional unsaturation, how 
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structural changes at the ligand level are perceived and transduced to the 
transcription level i.e. are there ligand-specific co-activators or response 
elements, whether there are DAF-12 outputs affected differentially by the 
different identified ligands, and finally do these ligands bind to other NHRs in 
C. elegans and/or other nematodes?  
In chapter 4, the chemical nature of the “death fluorescence” has been 
revealed. This blue fluorescence was earlier considered a consequence of 
age-related degradation products of proteins, and this work has confirmed that 
this is not the case: the blue death fluorescence is due to release of specific 
tryptophan catabolites. The discovery of anthranilic acid derivatives as 
fluorescent biomarker of death is therefore a significant discovery not just 
within the C. elegans community but the entire scientific community. 
Tryptophan degradation pathways have frequently been hypothesized to be 
correlated to aging and age-related diseases, (van der Goot and Nollen, 2013) 
and thus the finding that the production of a specific tryptophan catabolite is 
closely correlated with the onset of death is not a mere coincidence. More 
importantly, a number of questions have arisen from these results – why are 
anthranilic acid glucosylated, i.e. is it similar to glycosylation of toxic 
compounds and functions only as a transport mechanism, how and why is the 
in-situ production of anthranilic acid and its derivatives suddenly increased at 
death, and it will be interesting to ask whether this pathway is conserved in 
other animals and whether can we in fact visualize death in other living 
organisms as a function of the over production of a specific small molecule.  
These and many other questions have arisen and will arise from this 
work and will be duly investigated either by other members of the Schroeder 
lab, our collaborators or other ‘metabonauts’ – chemists and biologists 
interested to investigate the metabolomic terrain of living systems.  
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Future Outlook - Comparative metabolomics-based analysis of essential 
biological pathways in higher organisms 
As described in this dissertation, comparative metabolomics 
approaches utilizing 2D NMR-spectroscopy and LC/MS based methodology is 
extremely effective in understanding metabolic pathways in C. elegans. 
Parallel work from other members of the Schroeder Lab and its collaborators 
have confirmed the applicability of these techniques in microorganisms such 
as bacteria (Li et al., 2012) and fungi (Forseth et al., 2011), as well as other 
nematodes and P. pacificus (Bose et al., 2012). The key question now is how 
to move closer to our ultimate objective of elucidating small molecule-mediated 
signaling in higher organisms, so that it can help us provide more logical and 
more informative answers regarding biomedical questions that exist today asw 
well as new ones that may appear tomorrow. Encouraging in this respect, and 
challenging at the same time, is the knowledge that small molecules are 
involved in a significant portion of the signal transduction pathways that effect 
living systems, and that even today we have only uncovered or appreciated a 
small fraction of the structural and functional diversity they incorporate.  
As developers of metabolomics approaches, to move forward without 
being distracted by the fascinating complexity of small molecule architecture, 
we then have to focus on two key aspects of biological research : biological 
systems (i.e. organisms) and biological processes (i.e. metabolic pathways). 
The Preface of this dissertation introduced the necessity and reasoning for 
using model organisms (Hulme and Whitesides, 2011). In this regard, as 
shown in this dissertation as well as other contemporary work, C. elegans 
provides an excellent platform to ask and answer key questions about animal 
biology, so much so, that Sydney Brenner called this organism “Nature’s gift to 
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science”. However, like with all models, the use of C. elegans, despite its wide 
use as disease models, brings with it a certain set of limitations, especially the 
percentage of genetic overlap, which physiologically manifests as higher 
complexity in behavior, development and reaction to environmental responses. 
Therefore, looking at alternative models, especially vertebrate models such as 
puffer fish (Fugu rubripes) or frogs (Xenopus spp.) for specific pathways may 
become more beneficial. Of course if in the sudden discovery of a ‘disruptive 
technology’, propagation and genetic manipulation with mice (Mus musculus) 
becomes easier and cheaper, it would be the most ideal system to study small 
molecule signaling networks, mainly because of the easy interpolation of 
results and conclusions to the human model. 
Of note is also the existence of a new nematode model based on the 
organism Pristionchus pacificus. Originally studied as a satellite model to C. 
elegans, work in recent years has catapulted this organism into the limelight, 
primarily because of its higher complexity of many signaling networks, which 
may be due to its more complex ecological interactions (Bento et al., 2010). P. 
pacificus has revealed fascinating examples of phenotypic plasticity that are 
regulated by conserved signaling pathways, in part based on small molecules. 
Coupled with its closer proximity (than C. elegans) to parasitic nematodes 
make this an exceptionally useful and plausible “next step” for C. elegans 
researchers to proceed. Specifically regarding the work described in this 
research, investigation of the steroid profile of P. pacificus is an obvious future 
direction, in particular the identification of the Ppa-endogenous DAF-12 
ligands. Additionally, P. pacificus can also be the next frontier for investigating 
the tryptophan degradation pathway. We are already aware of the presence of 
a more evolved small-molecule bio-synthesis machinery in P. Pacificus (Bose 
et al., 2012) and it would be of course interesting to investigate the presence 
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or absence or structural modifications of the kynurenine pathway metabolite in 
this nematode. 
The identification of novel steroids in this study will increase motivation 
towards investigating the presence of similar structural modifications and 
corresponding enzymes in higher organisms e.g. ∆1 steroids, ∆1 desaturase 
enzyme, a P450 that specifically oxidises 3-α-hydroxy steroids, and tissue-
specific hormone production machinery. This work will encourage re-
consideration of steroid bio-transformations and their relevance for NHR-
hormone interactions.  
The author of this dissertation has been fortunate to have worked with 
two central biological pathways that define key physiological responses in 
living systems across phyla. Both steroid hormone-dependent NHR regulation 
and the involvement of tryptophan catabolites in central processes such as 
immunity, degeneration and death are fields of research that require further in-
depth analysis using multiple, distinct interdisciplinary approaches, and 
metabolomics will play an important role in these investigations. The results 
obtained in this study can be used as starting points to further investigate 
these processes in C. elegans and higher organisms.  
One important example for a small molecule-regulated pathway that 
remains poorly understood is that of molting. As previously mentioned, C. 
elegans contains 283 orphan nuclear receptors, of which 14 have similarity to 
NHRs of higher animals, and among these at least two, NHR-23 and NHR-25, 
have been implicated in the process of molting (Taubert et al., 2010). 
Elucidation of ligand structures of these receptors will be extremely important. 
The approach developed by this study requires an efficient method to detect 
bioactivity within metabolite extracts, and mutant organisms that are deficient 
of production of the target compound. In both these aspects, studying the 
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molting phenomena poses great challenges especially since mutants 
associated with defects in molting or developmental timing are often sterile or 
of limited viability. However, RNAi-based silencing of molting genes may 
provide a way to address this challenge.  
 A direct consequence from this work has been the renewed interest 
within Schroeder lab on the tryptophan degradation pathway and the 
association of tryptophan metabolites with the Aryl Hydrocarbon Receptor. The 
author of this dissertation strongly believes that AhR will play a major role in 
medicine in the next decade, primarily for two reasons: 1) the recent 
discoveries that, although AhR was discovered originally as a mediator of 
xenobiotic responses, this transcription factor actually plays a major role in 
regulating development and immunity across species, and 2) the possibility 
that specific tryptophan derived metabolites serve as the endogenous ligands 
of AhR. Not least because of its association with AhR, the tryptophan 
degradation pathway has recently come to the forefront of biomedical 
research, with increasing number of results pointing towards the involvement 
of tryptophan catabolites in disease pathways such as neurodegeneration, 
tumorigenesis and several primary metabolic pathways. The discovery of 
novel endogenous, tryptophan-derived ligand for Ahr-1 in C. elegans could 
therefore have important implications. This work has only shown some 
preliminary results regarding the kynurenine pathway mutants in C. elegans, 
and based on these initial results one can definitely hypothesize that a more 
extensive analysis of this pathway will lead to the characterization of more 
novel components of this widely conserved pathway, including perhaps the 
presence of a previously unrecognized enzyme. 
   A third focus area for future studies on metabolomics concerns 
signaling processes that mediate interactions of different organisms. We can 
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identify endogenous metabolites produced by an organism as a consequence 
of environmental, genetic changes. Can we extrapolate this and find out more 
about species cross-talk, host-pathogen interactions and symbiotic 
relationships among living systems. Humans have tried and are still trying to 
overcome barriers caused by language using our other sensory perceptions. Is 
this possible in a molecular level? There are already examples where 
organisms have been found “listening in” to the conversations of other 
organisms and using it to their benefit, and almost always this is because of 
the existence of receptors or sensory organs that detect a specific kind of 
small molecule. Can we then, use our metabolomics approaches to tap into 
these conversations, held in a universally accepted language based on small 
molecules?   
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APPENDIX A 
 
1. C. elegans Strains and Maintenance 
Nematode stocks were maintained on Nematode Growth Medium (NGM) 
plates made with Bacto agar (BD Biosciences) and seeded with bacteria (E. 
coli strain OP50) at 20 °C (http://www.wormbook.org/). The following C. 
elegans strains were used: wild type (N2, Bristol), daf-22(m130), daf-
22(ok693), daf-9(dh6), daf-9(dh6);daf-12(rh411rh61), hsd-1(mg345), glp-
1(e2141), glp-1(e2141);daf-36(k114). Compound mutants were constructed 
using standard techniques. Worms were grown at 20 °C for at least two 
generations under replete growth conditions prior to growing in liquid cultures.  
 
2. Liquid Cultures 
Worms from four 10 cm NGM agar plates were washed using M9-medium into 
a 100 mL S-complete medium pre-culture where they were grown for four days 
at 22 °C on a rotary shaker. Concentrated bacteria derived from 1 L of E. coli 
OP50 culture was added as food at days one and three. Subsequently, the 
pre-culture was divided equally into sixteen 500 mL Erlenmeyer flask 
containing 100 mL of S-complete medium on day 4, which was then grown for 
an additional 5 days at 22 °C on a rotary shaker and fed with concentrated 
bacteria ad lib. The cultures were harvested on day 5 and centrifuged to 
separate the supernatant media and worm pellets. At harvest, liquid cultures 
contained approximately 80% L1-L3 worms. The worm pellets were stored at -
20 °C until used for further analyses. 
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3. Preparation of Metabolome Extracts 
The frozen worm pellets were added to pre-cooled (-78 °C) 200 mL of 
methanol in a Waring laboratory blender and blended until no chunks 
remained. Methanol was evaporated in vacuo  at 20 °C and the residue 
resuspended in 300 mL of water. The resulting suspension was then frozen 
using a dry ice-acetone bath and lyophilized. The lyophilized residue was 
crushed to a fine powder using a mortar and pestle over 8 g granular sodium 
chloride. The powder was then extracted twice with 250 mL of 9:1 ethyl 
acetate:ethanol mixture over 12 h. The resulting yellow-brown suspension was 
filtered and the filtrate evaporated in vacuo at room temperature to produce 
the worm pellet metabolome extract used for chromatographic separations.  
 
All synthetic samples were synthesized in collaboration with Joshua Judkins 
(Frank Schroeder Lab) and will be reported in detail elsewhere.  
 
4. NMR Spectroscopic Instrumentation and Analysis 
NMR spectra were recorded on a Varian 900 MHz NMR spectrometer (899.9 
MHz for 1H, 226.7 MHz for 13C) equipped with a 5 mm 1H (13C/15N) cryogenic 
probe, a Varian INOVA 600 MHz NMR spectrometer (600 MHz for 1H, 151 
MHz for 13C) equipped with an HCN indirect detection probe, and a Varian 
INOVA 500 MHz NMR spectrometer (500 MHz for 1H, 125 MHz for 13C) 
equipped with an DBG broadband probe. Each spectrum was manually 
phased, baseline corrected and calibrated to solvent peaks (CHCl3 singlet at 
7.26 ppm; CHD2OD quintet at 3.31 ppm). Non-gradient phase-cycled 
dqfCOSY spectra were acquired using the following parameters: 0.8 s 
acquisition time, 500-900 complex increments, 16-64 scans per increment. 
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Obtained dqfCOSY spectra were zero-filled to 8k-16k × 4k and a cosine bell-
shaped window function was applied in both dimensions before Fourier 
transformation. NMR spectra were processed using Varian VNMR, 
MestreLabs’ MestReC, and MNova software packages. Dynamic range of the 
resulting spectra ranged from 300:1 to 500:1. For example, coupling constants 
could be determined for characteristic steroidal crosspeaks from dqfCOSY 
spectra containing as little as 5 µg Δ1,7-DA in a 2.5 mg enriched metabolome 
fraction.  
 
5. daf-9(dh6) Dauer Rescue Assay 
Plate based assay: Metabolome fractions were resuspended in ethanol, mixed 
with 40 µL of 5 x concentrated OP50 bacteria (from an overnight culture in LB 
media) and plated on 3 cm plates containing 3 mL NGM agar without added 
cholesterol. For rescue, ~100 eggs from a 4-8 hour egg lay were transferred 
onto the bacterial lawn, and scored for dauer arrest at 27 °C after 60 h. For 
rescue experiments with synthetic steroids (0.1 nM – 500 nM tested), 10 µL 
compounds in ethanol (or ethanol alone) were mixed with 40 µL 5X 
concentrated OP50 bacteria and plated. Final concentrations include the total 
volume of agar (3 mL). 100 nM Δ7-DA was used as positive control.  
 
Liquid Culture based assay:  Individual metabolome fractions were dried in 
vacuo and resuspended in 500 μL EtOH. 20-25 gravid daf-9(dh6) adults were 
picked onto three 6 cm NGM agar plates seeded with OP50 containing 25 μL 
of 10 μM ∆7-DA each and allowed to grow for three days. On the third day 
each of the plates were washed with M9 and treated with alkaline hypochlorite 
solution to isolate eggs from gravid adults. Isolated eggs were allowed to hatch 
in S-complete media without food, overnight. 100 μl of the resulting 
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synchronized L1 suspension was added to 400 μl of HB101 seeded S-
complete media and 5 μl of ethanol or metabolome fraction or ethanol solution 
of synthetic ligands (1.25 nM – 200 nM tested) per well of a 12 well plate. 
Wells were examined after 48 and 72 h and scored for dauers, recovered 
animals and intermediate worms with molting defects and/or mig phenotypes. 
For active metabolome fractions, additional assays using smaller amounts 
were conducted. 
 
Data obtained from both plate based and liquid culture assays are 
comparable. All figures in Chapter 1 and Appendix A are representative of 
data from plate based assays.  
 
6. Luciferase Assay for DAF-12 Transcriptional Activation 
Luciferase assays to determine transcriptional activation of DAF-12 were 
performed as described earlier (Bethke et al., 2009). Briefly, HEK-293T cells 
were seeded and transfected in 96-well plates with (pr well) 30 ng transcription 
factor vector, 30 ng of gfp expression vector, 30 ng of luciferase reporter, and 
5 ng β-galactosidase expression vector using the calcium phosphate 
precipitate method. Ethanol or ethanol solutions of ligands (synthetic DAs, 1 
nM – 3125 nM tested and metabolome fractions) were added 8h after 
transfection and the luciferase and β-galactosidase activities were measured 
by a Synergy 2 Biotek LC Luminometer, 16 h after compound addition. 100 nM 
Δ7-DA was used as positive control. Data was processed using GEN5 
software. Individual fractions were dried in vacuo and resuspended in 500 µL 
EtOH. 1 µL per 100 µL of media solution was added to each well. 
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7. Alphascreen Assay for Direct Binding of DAF-12 Ligand Candidates 
Direct binding of ligand candidates to DAF-12 was assessed by measuring 
ligand dependent interaction between a heterologously expressed DAF-12 
construct and the mammalian co-activator peptide, SRC1-4, in Alphascreen 
assays (Perkin Elmer). An N-terminally GST-6xHis-tagged DAF-12 construct 
(amino acids 281-753, which includes most of the hinge region and the entire 
LBD) was purified from BL21 (DE3) cells (Sigma) using a GT sepharose 
column followed by a size exclusion column. Purified DAF-12 (25 nM final 
concentration) and biotinylated SRC1-4 (synthetic biotin-
QKPTSGPQTPQAQQKSLLQQLLTE obtained from Anaspec, used at 50 nM 
final concentration), were incubated separately in plastic tubes for 20 min with 
Ni2+ chelate acceptor beads (for DAF-12) or streptavidin donor beads (for 
SRC1-4, 25 μg/mL final concentration, Perkin Elmer, Cat. No - 6760619C). 
They were then combined with subsequent addition of ligand candidates or 
ethanol (stored in glass vials) to obtain a final volume of 20 μL, and incubated 
for 60 min in white, low volume, 384 well Optiplates (Perkin Elmer). The plates 
were then read using a Synergy 2 Biotek LC luminometer using the 
manufacturer’s Alphascreen detection protocol. All solutions were made using 
assay buffer containing 25 mM HEPES (pH 7.4) and 100 mM NaCl. 
Cholesterol and heptadecanoic acid, assayed at 1 µM concentration as 
additional negative controls, gave no signal (Figure S3C). Addition of CHAPS 
(40 μM) did not significantly affect assay results, whereas addition of 0.01% 
BSA reduced signal. All incubations were carried out at room temperature in 
the dark. Figure 4H shows combined data derived from at least independent 
experiments (each N = 4 or higher) run on three or more different days. 
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8. GC/MS Instrumentation and Sample Preparation 
GC/MS analysis was carried out with an Agilent Technologies 6890N Network 
GC system with a DB-5MS+DG column (25 µm, 30 m x 0.25 mm) operating in 
split-less mode, connected to a JEOL JMS-GCmateII mass spectrometer. (For 
details about GC conditions, see Extended Experimental Procedures). 
Methylation of 3-keto-DAs: synthetic standards or 1-10 % of active 
metabolome fractions were evaporated in vacuo and resuspended in 
toluene:methanol (500 µL, 3:2), followed by the drop-wise addition of 
trimethylsilyldiazomethane (120 µL, 2 M solution in Et2O) with stirring. The 
reaction was stirred at room temperature for 30 min, quenched with acetic 
acid, evaporated in vacuo, and resuspended in dichloromethane (30-200 µL). 
Of this solution, 1-5 µL were injected per GC/MS analysis. Silylation of 3-
hydroxy-DAs: Synthetic standards or 1-10 % of active fractions were 
evaporated in vacuo and a mixture (100 µL) of 3% 1-(trimethylsilyl)imidazole 
(TMSIM) in N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) was added 
with stirring at 80 °C for 45 min. The reaction mixture was evaporated in vacuo 
and resuspended in dichloromethane (30-200 µL). Of this solution, 1-5 µL 
were injected per GC/MS run. 
 
9. HPLC Enrichment Protocol 
Metabolome fractions derived from the Combiflash® method described above 
were evaporated in vacuo, resuspended in 250 μL of methanol and submitted 
to HPLC, using an Agilent 1100 Series HPLC system equipped with an Agilent 
Eclipse XDB C-18® column (25 cm x 9.4 mm, 5 µm particle diameter). A 0.1% 
acetic acid in water (aqueous) – 9:1 acetonitrile : methanol (organic) solvent 
system was used, starting with 70% organic solvent for 3 min, which was 
increased linearly to 100% over a period of 20 min and continued at 100% 
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organic solvent for 2 min. One minute fractions were collected using a 
Teledyne ISCO Foxy 200 X-Y Fraction Collector® connected to the HPLC 
from 12 to 36 min. Collected fractions were individually evaporated in vacuo 
for further analysis.  
 
10. Life Span Assay 
Life span assays were performed in Percival I-36NL incubators at 20 °C. After 
alkaline hypochlorite treatment and two generations of growth, animals were 
raised at 25 °C, and sterile young adult animals were placed onto NGM plates 
seeded with 10X concentrated E. coli OP50, containing 100 nM dafachronic 
acid or ethanol vehicle control. Every fourth day, animals were transferred to 
new NGM plates with freshly added dafachronic acid or vehicle control. Activity 
of dafachronic acid in each batch of plates was confirmed by assessing the 
ability of dafachronic acid to rescue daf-9(dh6) dauer arrest, compared to 
vehicle control. Animal viability was assessed visually or with gentle prodding. 
GraphPad Prism (GraphPad Software, La Jolla, CA) was used for data 
representation and statistical analysis. These experiments were carried out by 
Josh Wollam (Adam Antebi Lab, MPI Cologne) and Kathlyn J. Dumas (Patrick 
Hu Lab, Univ. of Michigan). 
 
11. GC/MS Method 
GC conditions: Injector was kept at 240 °C and 1 mL/min He flow was 
maintained. Initial column temperature was at 120 °C for 1.4 min, then 
increased to 320 °C at a rate of 7 °C/min, and maintained at 320 °C for 10 min.  
 
MS conditions: Electron impact ionization (EI) operated at 70 eV. For synthetic 
samples (high concentrations, >100 ng/μL), MS was first operated in scanning 
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mode for a mass range of m/z 35-500 for 3-keto-DA methyl ester and 3-keto-
steroids, and m/z 35-650 for 3-OH-DA TMS derivatives to select for the most 
abundant fragment ions for each compound. For low concentrations (<5 ng/μL) 
of synthetic samples and metabolome fractions, MS was operated in Selective 
Ion Monitoring (SIM) mode and the following ions were selectively observed: 
m/z = 428, 271, 229 (∆7-DA); 426, 269, 227 (∆1,7-DA); 430, 398, 231 (∆0-DA); 
428, 305, 229, 124 (∆4-DA); 545, 470, 255 (3α- and 3β-OH-∆7-DA); 384, 261, 
229 (4-cholesten-3-one).  
 
12. Quantification of DAs from Metabolome Fractions via SIM-GC/MS 
GC/MS Data was analyzed using Shrader Analytical and Consulting 
Laboratories, Inc.’s TSSPro 3.0 software package. Quantification of DAs was 
performed by integration of GC/MS peaks from the following ion traces: m/z = 
428 (∆7-DA); 426 (∆1,7-DA); 231 (∆0-DA); 428 (∆4-DA); 255 (3α- and 3β-OH-∆7-
DA). Dafachronic acid concentrations were calculated using response factors 
determined from synthetic standards. Mass spectrometer response was 
roughly linear (<5% error) for amounts of 10 pg to 5 ng per compound 
injection. 
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Figure A.1. Biological activity of metabolite fractions obtained from C. 
elegans. Assessment of DAF-12 transcriptional activation in the in vitro 
luciferase assay in HEK-293T cells (left) and dauer rescue activity in daf-
9(dh6) worms (right) with metabolome fractions obtained from (a) wild type (b) 
daf-22 animals. These data show that daf-9(dh6) dauer rescue activity is 
generally higher in daf-22 mutant metabolome fractions. (c) DIC images of daf-
9(dh6) worms showing different phenotypes scored in the dauer rescue assay. 
Dauer (top left), adult recovered (top right), intermediate phenotypes showing 
molting defects (bottom left, arrows point to incompletely shed cuticle from 
previous molt), fully recovered late L4 (bottom center), and intermediate 
phenotypes showing incomplete gonad migration (bottom right). Yellow lines 
indicate gonadal shape in shown mig phenotypes. 
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Figure A.2. daf-9 independent sterols in metabolome fractions. Structures 
of major epidioxy sterol derivatives that elute with Δ7 and Δ1,7-DAs in active 
fractions but can also be observed in corresponding inactive daf-9;daf-12 
fractions. 
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Figure A.3. Identification of Δ1,7-DA in active region I. Sections of dqfCOSY 
spectra (600 MHz, CDCl3) used for identification of Δ
1,7-DA in C. elegans. (a) 
Natural Δ1,7-DA in HPLC-enriched fraction 25-6 (Figure 2.5) from daf-22 
mutant. (b) Synthetic Δ1,7-DA. Characteristic crosspeaks are boxed blue. 
  
151 
 
 
 
b 
a 
ppm (f2)
1.502.002.50
1.50
2.00
2.50
ppm (f1)
ppm (f2)
1.502.002.50
1.50
2.00
2.50
ppm (f1)
152 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.4. Identification of of Δ7-DA in active region I. Sections of 
dqfCOSY spectra (600 MHz, CDCl3) confirming presence of Δ
7-DA in C. 
elegans. (a) Natural Δ7-DA in HPLC-enriched fraction 25-8 from daf-22 mutant 
(Figure 2.5). (b) Synthetic Δ7-DA. Characteristic crosspeaks are boxed blue. 
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Figure A.5.EI-MS for methyl esters of DAs in active region I. EI-MS for 
methyl esters of (a) Δ7-DA and (b) Δ1,7-DA. (*) Indicates the ion fragments 
subsequently used for SIM-GC/MS analyses of these compounds in 
metabolome fractions.   
a 
b 
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Figure A.6. SIM-GC/MS analyses of DAs in active region I. SIM-GC/MS 
analyses showing characteristic fragment ion traces for methyl esters of (a) 
natural Δ1,7-DA (left), natural Δ7-DA (right) in HPLC-enriched fractions 25-6 
and 25-8 respectively from daf-22, (b) synthetic Δ1,7-DA (left), and synthetic 
Δ7-DA (right). (c) Characteristic EI-MS fragments of Δ1,7-DA methyl ester (left) 
and Δ7-DA methyl ester (right) 
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Figure A.7.  EI-MS for standard 3-OH-∆7-DA TMS derivatives. (*) Indicates 
the ion fragments subsequently used for SIM-GC/MS identification of these 
compounds in natural samples. (a) 3α-OH-Δ7-DA (b) 3β-OH-Δ7-DA. The red 
box indicates the ion fragment m/z = 213 that have been implicated in a 
previous publication4 as belonging to a putative DAF-12 ligand. 
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Figure A.8. Identification of 3α-OH-Δ7-DA in active region II. SIM-GC/MS 
analysis showing characteristic fragment ion traces for TMS derivative of 3α-
OH-Δ7-DA. (a) Natural 3α-OH-Δ7-DA in HPLC-enriched fraction from active 
region II. (b) Synthetic 3α-OH-Δ7-DA. (c) Characteristic EI-MS fragments of 
3α-OH-Δ7-DA TMS derivative shown in (e) and (f). (d) GC/MS total ion 
chromatograms (TIC) of synthetic 3α-OH-Δ7-DA, synthetic 3β-OH-Δ7-DA, and 
natural 3-OH-Δ7-DA TMS derivatives. The GC retention times for the natural 
compound matches precisely with that of synthetic 3α-OH-Δ7-DA and is 
distinctly different from that of the 3β-isomer. (*) indicates small amounts of 
impurities in the synthetic 3β-OH-Δ7-DA sample. 
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Figure A.9. Bioactivity of synthetic DAs. (a) Lifespan extension due to the 
loss of the germline-deficient glp-1 mutants is not affected by the addition of 
100 nM of the most abundant DAF-12 ligands, Δ7- and Δ1,7-DA. (b) DAF-12-
ligand candidates produced signal in the Alphascreen assay only in the 
presence of SRC1-4 peptide. (c) 500 nM cholesterol and heptadecanoic acid 
did not produce any signal in the Alphascreen assay. 
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Figure A.10. SIM-GC/MS analysis did not reveal ∆4-DA as a significant C. 
elegans metabolite. (a) EI-MS for Δ4-DA methyl ester. (*) Indicates the ion 
fragments subsequently used for SIM-GC/MS analysis of this compound in 
natural samples. (b) SIM-GC/MS total ion chromatograms (TIC) of synthetic 
Δ4-DA methyl ester, 1% injection of methylated inactive fraction 26 from daf-22 
to which trace amounts of synthetic Δ4-DA (100 ng, ~20-fold less than Δ7-, 
Δ1,7-DAs in active metabolome fractions) had been added, and 100% injection 
of a methylated and HPLC-enriched natural fraction matching the LC retention 
time of synthetic Δ4-DA.  
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Figure A.11. Identification of 4-cholesten-3-one and lathosterone from 
daf-22. Sections of dqfCOSY spectra (600 MHz, CDCl3) confirming presence 
of 4-cholesten-3-one in C. elegans. (a) 4-Cholesten-3-one in enriched natural 
fraction from daf-22. (b) Synthetic 4-cholesten-3-one. Characteristic 
crosspeaks are boxed blue.   
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Figure A.11. Identification of 4-cholesten-3-one and lathosterone from 
daf-22. (c) EI-MS for 4-cholesten-3one. (*) Indicates the ion fragments 
subsequently used for SIM-GC/MS analysis of this compound in natural 
samples. SIM-GC/MS analysis showing characteristic fragment ion traces for 
(d) enriched natural fraction from daf-22 containing 4-cholesten-3-one and (e) 
synthetic 4-cholesten-3-one. 
 
 
 
 
c 
d 
e 
167 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.11. Identification of 4-cholesten-3-one and lathosterone from 
daf-22. Sections of dqfCOSY spectra (600 MHz, CDCl3) confirming presence 
of lathosterone in C. elegans. (f) Lathosterone in enriched natural fraction from 
daf-22. (g) Synthetic lathosterone. Characteristic crosspeaks are boxed blue. 
  
168 
  
f 
g 
169 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.12. Endogenous concentrations of DAs. In vivo concentrations of 
Δ7-DA, Δ1,7-DA, and Δ0-DA derived from SIM-GC/MS-based quantification in 
wild-type (N2), daf-22, and steroid metabolism mutants (error bars, SD). 
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Table A.1. EC50 values of synthetic DAs for luciferase, Alphascreen and dauer 
rescue assays as well as HPLC retention times for synthetic DAs. 
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Spectroscopic Data  
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Table A.2 NMR Spectroscopic Data of Δ1,7-DA. 1H (600 MHz), 13C (151 MHz), 
and HMBC NMR spectroscopic data for Δ1,7-DA in CDCl3. Chemical shifts 
were referenced to (CHCl3) = 7.26 ppm and (CDCl3) = 77.16 ppm. 
 
Carbon 
No. 
 
(ppm)
Proton 
No. 
 (ppm) J (Hz) HMBC Correlations 
1 157.3 1-H 7.01 J1,2=10 C-10, C-9, C-5, C-3 
2 127.1 2-H 5.89 
 
C-10, C-4 
3 199.8 ---- ---- ---- ---- 
4 40.1 4-H 2.34   C-3, C-10 
    4-H 2.34   C-3, C-10 
5 39.6 5-H 2.05     
6 28.7 6-H 1.89-1.94   C-8 
    6-H 1.89-1.94     
7 117.8 7-H 5.25     
8 138.8 ---- ---- ---- ---- 
9 45.2 9-H 1.93     
10 39.6 ---- ---- ---- ---- 
11 21.5 11-H 1.76     
    11-H 1.58     
12 39.2 12-H 1.27     
    12-H 2.09     
13 43.5 ---- ---- ---- ---- 
14 55.1 14-H 1.83     
15 23.0 15-H 1.53     
    15-H 1.42     
16 27.8 16-H 1.89     
    16-H 1.28     
17 55.9 17-H 1.82     
18 11.9 18-H 0.57 ---- 
C-12, C-13, C-14, C-
17 
19 12.6 19-H 0.95 ---- C-1, C-10, C-5, C-9 
20 36.1 20-H 1.38     
21 18.7 21-H 0.93 J21,22=6.4   
22 35.7 22-H 1.05     
    22-H 1.39     
23 23.9 23-H 1.21     
    23-H 1.39     
24 34.0 24-H 1.37     
    24-H 1.68     
25 38.9 25-H 2.48 J25,26=6.9 C-23, C-24, C-27 
26 17.0 26-H 1.19 
 
C-25, C-27, C-24 
27 179.3 ---- ---- ---- ---- 
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Table A.3. NMR Spectroscopic Data of 3α-OH-∆7-DA. 1H (600 MHz), 13C (151 
MHz), and HMBC NMR spectroscopic data for 3α-OH-∆7-DA in CDCl3. 
Chemical shifts were referenced to (CHCl3) = 7.26 ppm and (CDCl3) = 77.16 
ppm. 
Carbon 
No. 
δ(ppm) 
Proton 
No. 
δ (ppm) J (Hz) HMBC Correlations 
1 31.9 1-H  1.43   C-3 
    1-H  1.55   C-3, C-5 
2 28.7 2-H  1.4-1.63     
    2-H  1.4-1.63     
3 66.4 3-H 4.07 J3-2= 8.7, J3-4= 3.5  
4 35.4 4-H  1.40-1.52     
    4-H  1.40-1.52     
5 34.6 5-H 1.74 ---- C-10 
6 29.5 6-H  1.67-1.72     
    6-H  1.67-1.72     
7 117.5 7-H 5.17     
8 139.6 ---- ---- ---- ---- 
9 49.4 9-H 1.75     
10 34.7 ---- ---- ---- ---- 
11 21.2 11-H  1.58     
    11-H  1.43     
12 39.5 12-H  1.24     
    12-H  2.02     
13 43.4 ---- ---- ---- ---- 
14 55.0 14-H 1.80     
15 22.9 15-H  1.53   C-8 
    15-H  1.39     
16 29.6 16-H  1.86     
    16-H  1.25     
17 55.9 17-H 1.20     
18 11.9 18-H 0.53   C-12, C-13, C-14, C17 
19 12.0 19-H 0.77   C-1, C-10, C-5, C-9 
20 36.0 20-H 1.36     
21 18.9 21-H 0.92 J21-20 = 6.5 C-20, C-17, C-22 
22 35.7 22-H  1.38     
    22-H  1.05     
23 23.7 23-H  1.20     
    23-H  1.36     
24 34.0 24-H  1.37     
    24-H  1.66     
25 38.8 25-H 2.49 J25-26 = 7.0 C-23, C-24, C-27  
26 17.0 26-H 1.19 
 
C-24, C-25, C-27 
27 179.0 ---- ---- ---- ---- 
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NMR Spectra of Synthetic Compounds 
 
1
H NMR Spectrum (600 MHz, CDCl3) of (25S)-∆
1,7
-Dafachronic Acid 
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dqfCOSY Spectrum (600 MHz, CDCl3) of (25S)-∆
1,7
-Dafachronic Acid 
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HMQC Spectrum (600 MHz for 
1
H, 151 MHz for 
13
C, CDCl3) of (25S)-∆
1,7
-
Dafachronic Acid 
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HMBC Spectrum (600 MHz for 
1
H, 151 MHz for 
13
C, CDCl3) of (25S)-∆
1,7
-
Dafachronic Acid 
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1
H NMR Spectrum (600 MHz, CDCl3) of 3-OH-(25S)-∆
7
-Dafachronic Acid  
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dqfCOSY Spectrum (600 MHz, CDCl3) of 3-OH-(25S)-∆
7
-Dafachronic Acid 
  
181 
 
HMQC Spectrum (600 MHz for 
1
H, 151 MHz for 
13
C, CDCl3) of 3-OH-(25S)-∆
7
-
Dafachronic Acid 
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APPENDIX B 
 
1. C. elegans Strains and Maintenance 
Nematode stocks were maintained on Nematode Growth Medium (NGM) 
plates made with Bacto agar (BD Biosciences) and seeded with bacteria (E. 
coli strain OP50) at 20 °C (http://www.wormbook.org/). The following C. 
elegans strains were used: wild type (N2, Bristol), daf-22(m130), daf-
22(ok693), daf-9(dh6), daf-9(dh6);daf-12(rh411rh61), hsd-1(mg345), hsd-
1(mg433), hsd-1(mg433);daf-22(ok693), daf-36(k114), daf-36(k114);daf-
22(ok693), dhs-16(tm1890);daf-22(m130), strm-1(tm1781), glp-1(e2141), glp-
1(e2141);daf-36(k114), daf-40(hd100), daf-36(k114);daf-9(k182), daf-
40(hd100);daf-12(rh61rh411), daf-40(hd100);daf-36(k114), daf-40(hd100);dhs-
16(tm1890),), daf-40(hd100);daf-9(dh6), daf-40(hd100);daf-2(e1368), daf-
40(hd100);daf-22(m130), and dhIs839(Pdaf-40::daf-40::gfp;coel::rfp). 
 Compound mutants were constructed using standard techniques. Worms 
were grown at 20 °C for at least two generations under replete growth 
conditions prior to growing in liquid cultures.  
 
2. Liquid Cultures 
Worms from four 10 cm NGM agar plates were washed using M9-medium into 
a 100 mL S-complete medium pre-culture where they were grown for four days 
at 22 °C on a rotary shaker. Concentrated bacteria derived from 1 L of E. coli 
OP50 culture was added as food at days one and three. Subsequently, the 
pre-culture was divided equally into sixteen 500 mL Erlenmeyer flask 
containing 100 mL of S-complete medium on day 4, which was then grown for 
an additional 5 days at 22 °C on a rotary shaker and fed with concentrated 
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bacteria ad lib. The cultures were harvested on day 5 and centrifuged to 
separate the supernatant media and worm pellets. At harvest, liquid cultures 
contained approximately 80% L1-L3 worms. The worm pellets were stored at -
20 °C until used for further analyses. 
 
3. Preparation of Metabolome Extracts  
 
For NMR studies. The frozen worm pellets were added to pre-cooled (-78 °C) 
200 mL of methanol in a Waring laboratory blender and blended until no 
chunks remained. Methanol was evaporated in vacuo at 20 °C and the residue 
resuspended in 300 mL of water. The resulting suspension was then frozen 
using a dry ice-acetone bath and lyophilized. The lyophilized residue was 
crushed to a fine powder by a mortar and pestle using ~8 g granular sodium 
chloride. The powder was then extracted twice with 250 mL of 9:1 ethyl 
acetate:ethanol mixture over 12 h. The resulting yellow-brown suspension was 
filtered and the filtrate evaporated in vacuo at room temperature to produce 
the worm pellet metabolome extract used for chromatographic separations. 
 
C. elegans Lipid Extracts for GC/MS/MS. This methodology was used for 
preparing GC samples in the Adam Antebi Lab. Worms were grown on 10 cm 
NGM agar plates seeded with OP50 bacteria at 20°C. Gravid adults were 
bleached and the resulting embryos transferred to 2-3 additional 10 cm plates. 
Two to three successive rounds of growth and lysis were performed. For the 
final round, worms were grown until the L3 stage, harvested, frozen in liquid 
nitrogen and stored at -80 °C. Thawed worms were homogenized by 
sonication or with an Emulsi-flex C-5 homogenizer (Avestin), and total lipids 
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(plus 1 μg cholesterol-d7 and 5β-cholanic acid) were extracted with 2:1 
chloroform:methanol. The resulting chloroform layer was dried under argon 
 
All synthetic samples for these experiments were synthesized in collaboration 
with Josh Judkins and their synthesis will be described in detail elsewhere.  
 
 
4. NMR Spectroscopic Instrumentation and Analysis 
NMR spectra were recorded on a Varian 900 MHz NMR spectrometer (899.9 
MHz for 1H, 226.7 MHz for 13C) equipped with a 5 mm 1H (13C/15N) cryogenic 
probe, a Varian INOVA 600 MHz NMR spectrometer (600 MHz for 1H, 151 
MHz for 13C) equipped with an HCN indirect detection probe, and a Varian 
INOVA 500 MHz NMR spectrometer (500 MHz for 1H, 125 MHz for 13C) 
equipped with an DBG broadband probe. Each spectrum was manually 
phased, baseline corrected and calibrated to solvent peaks (CHCl3 singlet at 
7.26 ppm; CHD2OD quintet at 3.31 ppm). Non-gradient phase-cycled 
dqfCOSY spectra were acquired using the following parameters: 0.8 s 
acquisition time, 500-900 complex increments, 16-64 scans per increment. 
Obtained dqfCOSY spectra were zero-filled to 8k-16k × 4k and a cosine bell-
shaped window function was applied in both dimensions before Fourier 
transformation. NMR spectra were processed using Varian VNMR, 
MestreLabs’ MestReC, and MNova software packages. Dynamic range of the 
resulting spectra ranged from 300:1 to 500:1. For example, coupling constants 
could be determined for characteristic steroidal crosspeaks from dqfCOSY 
spectra containing as little as 5 µg Δ1,7-DA in a 2.5 mg enriched metabolome 
fraction.  
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5. daf-9(dh6) Dauer Rescue Assay 
Plate based assay: Metabolome fractions were resuspended in ethanol, mixed 
with 40 µL of 5 x concentrated OP50 bacteria (from an overnight culture in LB 
media) and plated on 3 cm plates containing 3 mL NGM agar without added 
cholesterol. For rescue, ~100 eggs from a 4-8 hour egg lay were transferred 
onto the bacterial lawn, and scored for dauer arrest at 27 °C after 60 h. For 
rescue experiments with synthetic steroids (0.1 nM – 500 nM tested), 10 µL 
compounds in ethanol (or ethanol alone) were mixed with 40 µL 5X 
concentrated OP50 bacteria and plated. Final concentrations include the total 
volume of agar (3 mL). 100 nM Δ7-DA was used as positive control.  
 
Liquid Culture based assay:  Individual metabolome fractions were dried in 
vacuo and resuspended in 500 μL EtOH. 20-25 gravid daf-9(dh6) adults were 
picked onto three 6 cm NGM agar plates seeded with OP50 containing 25 μL 
of 10 μM ∆7-DA each and allowed to grow for three days. On the third day 
each of the plates were washed with M9 and treated with alkaline hypochlorite 
solution to isolate eggs from gravid adults. Isolated eggs were allowed to hatch 
in S-complete media without food, overnight. 100 μl of the resulting 
synchronized L1 suspension was added to 400 μl of HB101 seeded S-
complete media and 5 μl of ethanol or metabolome fraction or ethanol solution 
of synthetic ligands (1.25 nM – 200 nM tested) per well of a 12 well plate. 
Wells were examined after 48 and 72 h and scored for dauers, recovered 
animals and intermediate worms with molting defects and/or mig phenotypes. 
For active metabolome fractions, additional assays using smaller amounts 
were conducted. 
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6. Luciferase Assay for DAF-12 Transcriptional Activation 
Luciferase assays to determine transcriptional activation of DAF-12 were 
performed as described earlier (Bethke et al., 2009). Briefly, HEK-293T cells 
were seeded and transfected in 96-well plates with (pr well) 30 ng transcription 
factor vector, 30 ng of gfp expression vector, 30 ng of luciferase reporter, and 
5 ng β-galactosidase expression vector using the calcium phosphate 
precipitate method. Ethanol or ethanol solutions of ligands (synthetic DAs, 1 
nM – 3125 nM tested and metabolome fractions) were added 8h after 
transfection and the luciferase and β-galactosidase activities were measured 
by a Synergy 2 Biotek LC Luminometer, 16 h after compound addition. 100 nM 
Δ7-DA was used as positive control. Data was processed using GEN5 
software. Individual fractions were dried in vacuo and resuspended in 500 µL 
EtOH. 1 µL per 100 µL of media solution was added to each well. 
 
8. Biochemical experiments 
These experiments were carried out in collaboration with Josh Wollam (Adam 
Antebi Lab, MPI Cologne).  
 
Isolation of Microsomes. Isolation of microsomes from HEK293T cells was 
performed as described (Bozidis et al 2007).  Cells were grown in T-75 flasks 
and transfected with vector only or FLAG-tagged DAF-40. Expression of DAF-
40 was verified by immunoblot, using anti-FLAG antibodies (Sigma). 
Microsomal fractions were resuspended in 0.1 M KPO4 buffer, pH 7.4, 
containing 1 mM EDTA and 20 % glycerol, and stored at -80 °C.  
 
Microsomal Incubations. Microsomes were thawed on ice and brought to 80 
µg/mL in 0.1 M KPO4 buffer, pH 7.4, containing 1 mM EDTA, 0.5 pmol purified 
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recombinant human cytochrome P450 reductase, and 0.1 % hematin. 
Substrates were added at 100 µM in 0.25 mL total volume, pre-incubated for 5 
minutes at 37 °C, and reacted with 1 mM NAD for 16 hours at 37 °C. 
Reactions were processed by extracting twice with 1 mL MTBE, combining the 
top layers and drying under argon. 0.25 μg of cholesterol-d7 or 5β-cholanic 
acid was added as an internal standard for extractions. 
 
Sterol Supplementation Experiments. Metabolite extract fractions were 
resuspended in ethanol, mixed with 40 μL 5X concentrated OP50 bacteria and 
plated on 3 cm plates containing 3 mL NGM agar without added cholesterol. 
For rescue, ~100 embryos from a 4-8 hour egg lay were transferred onto the 
bacterial lawn and scored for dauer arrest at 27°C after 48 hours. For 
experiments with pure steroids, 10 μL compounds in ethanol (or ethanol alone) 
were mixed with 40 μL 5X concentrated OP50 bacteria and plated. Final 
concentrations include the total volume of agar (3 mL).  Dauer arrest was 
scored after 60 hours at 20 °C and after 48 hours at 25 °C and 27 °C. 
 
qRT-PCR. MicroRNA detection was accomplished using a protocol modified 
from a previous report (Chen et al.).  Briefly, total RNA was purified from L3 
stage larvae using TRIzol (Invitrogen) and the miRNeasy kit (Qiagen). TaqMan 
MicroRNA Reverse Transcription kit (Applied Biosystems) was used to 
generate cDNA with microRNA-specific primers. qRT-PCR was performed with 
Power SYBR Green master mix (Applied Biosystems) according to the 
manufacturer’s instructions. Sno-RNA U18 was used as an internal control for 
microRNA detection. 
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9. HPLC Enrichment Protocol 
Metabolome fractions derived from the Combiflash® method described above 
were evaporated in vacuo, resuspended in 250 μL of methanol and submitted 
to HPLC, using an Agilent 1100 Series HPLC system equipped with an Agilent 
Eclipse XDB C-18® column (25 cm x 9.4 mm, 5 µm particle diameter). A 0.1% 
acetic acid in water (aqueous) – 9:1 acetonitrile : methanol (organic) solvent 
system was used, starting with 70% organic solvent for 3 min, which was 
increased linearly to 100% over a period of 20 min and continued at 100% 
organic solvent for 2 min. One minute fractions were collected using a 
Teledyne ISCO Foxy 200 X-Y Fraction Collector® connected to the HPLC 
from 12 to 36 min. Collected fractions were individually evaporated in vacuo 
for further analysis. 
 
10. GC/MS Instrumentation and Sample Preparation 
GC/MS analysis was carried out with an Agilent Technologies 6890N Network 
GC system with a DB-5MS+DG column (25 µm, 30 m x 0.25 mm) operating in 
split-less mode, connected to a JEOL JMS-GCmateII mass spectrometer. (For 
details about GC conditions, see Extended Experimental Procedures). 
Methylation of 3-keto-DAs: synthetic standards or 1-10 % of active 
metabolome fractions were evaporated in vacuo and resuspended in 
toluene:methanol (500 µL, 3:2), followed by the drop-wise addition of 
trimethylsilyldiazomethane (120 µL, 2 M solution in Et2O) with stirring. The 
reaction was stirred at room temperature for 30 min, quenched with acetic 
acid, evaporated in vacuo, and resuspended in dichloromethane (30-200 µL). 
Of this solution, 1-5 µL were injected per GC/MS analysis. Silylation of 3-
hydroxy-DAs: Synthetic standards or 1-10 % of active fractions were 
evaporated in vacuo and a mixture (100 µL) of 3% 1-(trimethylsilyl)imidazole 
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(TMSIM) in N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) was added 
with stirring at 80 °C for 45 min. The reaction mixture was evaporated in vacuo 
and resuspended in dichloromethane (30-200 µL). Of this solution, 1-5 µL 
were injected per GC/MS run. 
 
11. GC/MS Method 
GC conditions: Injector was kept at 240 °C and 1 mL/min He flow was 
maintained. Initial column temperature was at 120 °C for 1.4 min, then 
increased to 320 °C at a rate of 7 °C/min, and maintained at 320 °C for 10 min.  
 
MS conditions: Electron impact ionization (EI) operated at 70 eV. For synthetic 
samples (high concentrations, >100 ng/μL), MS was first operated in scanning 
mode for a mass range of m/z 35-500 for 3-keto-DA methyl ester and 3-keto-
steroids, and m/z 35-650 for 3-OH-DA TMS derivatives to select for the most 
abundant fragment ions for each compound. For low concentrations (<5 ng/μL) 
of synthetic samples and metabolome fractions, MS was operated in Selective 
Ion Monitoring (SIM) mode and the following ions were selectively observed: 
m/z = 428, 271, 229 (∆7-DA); 426, 269, 227 (∆1,7-DA); 430, 398, 231 (∆0-DA); 
428, 305, 229, 124 (∆4- - -OH-∆7-DA); 384, 261, 
229 (4-cholesten-3-one).  
 
12. Quantification of DAs from Metabolome Fractions via SIM-GC/MS 
GC/MS Data was analyzed using Shrader Analytical and Consulting 
Laboratories, Inc.’s TSSPro 3.0 software package. Quantification of DAs was 
performed by integration of GC/MS peaks from the following ion traces: m/z = 
428 (∆7-DA); 426 (∆1,7-DA); 231 (∆0-DA); 428 (∆4- - -OH-
∆7-DA). Dafachronic acid concentrations were calculated using response 
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factors determined from synthetic standards. Mass spectrometer response 
was roughly linear (<5% error) for amounts of 10 pg to 5 ng per compound 
injection.  
 
13. GC/MS/MS Analysis 
These experiments were carried out by Daniel Magner (Adam Antebi Lab, MPI 
Cologne) Samples were analyzed by GC/MS/MS on a 7000A Triple 
Quadrupole GC/MS instrument (Agilent Technologies) equipped with an ESI 
source and an HP-5MS column. Briefly, lipid extracts were spiked with 
cholesterol-d7 or 5β-cholanic acid as internal standards, derivitized with an 
activated N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA)/NH4I mixture 
followed by Fluka III silylation mixture (for sterols) or with 
trimethylsilyldiazomethane (for bile acids), and analyzed in MRM mode. The 
following transitions were observed: 5β-cholanic acid (m/z 374.3264.0) and 
Δ7-dafachronic acid (m/z 428.3229.1).  Data was normalized to total protein 
content, as determined by Bradford Assay.  
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Figure B.1. Detection of 3β-OH-Δ7-DA in active region II of hsd-1;daf-22. 
Comparison of representative sections of 1H-NMR spectra of active HPLC-
enriched fractions from hsd-1;daf-22 active region II with synthetic 3α-OH-Δ7-
DA and 3β-OH-Δ7-DA reveals the presence of 3α-OH-Δ7-DA in fraction 27-11 
and 3β-OH-Δ7-DA in fraction 27-9 in roughly equal amounts. 
 
  
 
Figure B.2. Confirmation of the presence of Δ0-DA in active region I of 
daf-36;daf-22. SIM-GC/MS analysis showing characteristic fragment ion 
traces for Δ0-DA methyl ester. (a) Natural Δ0-DA in metabolome fraction 25 
from daf-36;daf-22 mutant. (b) Synthetic Δ0-DA. (c) Characteristic EI-MS 
fragments of Δ0-DA methyl ester shown in (a) and (b).  
193 
 
Figure B.3. Bioactivity of mutant metabolome fractions. Assessment of 
DAF-12 ligand content using the in vitro luciferase assay in HEK-293T cells 
(left) and the in vivo daf-9(dh6) dauer rescue (right) with metabolome fractions 
from (top) dhs-16;daf-22 and (bottom) strm-1. 
 
Figure B.4. daf-40 Phenotypes and Regulation are Consistent with a Role 
in DA Production. daf-40(hd100) mutants show gonadal Mig phenotypes on 
NGM without added cholesterol (Image Courtesy – Josh Wollam). 
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Figure B.5. Sterol Supplementation Experiments Reveal Differences in 
daf-40 from Other DA Synthetic Mutants. (A) Rescue of the Daf-c 
phenotypes of daf-40(hd100) mutants at 27 °C with 33 μM concentration of 
sterols. All compounds tested partially rescued, although only the DAs 
provided complete rescue (N=3, mean ± SEM). (B) Rescue of the daf-9(k182) 
hypomorphic allele is seen only with the DAs. (C) daf-36(k114) null mutants 
are rescued by 7-dehydrocholesterol (7-dehydrochol) and proposed 
downstream compounds (N=3, mean ± SEM). (D) daf-40;daf-36 double 
mutants are rescued by 7-dehydrocholesterol and downstream compounds but 
not by cholesterol (N=2, mean ± range), similar to daf-36 single mutant. (E) 
daf-40;daf-9(k182) double mutants are 100% Daf-c, and are only rescued by 
the DAs, similar to the daf-9 single mutant (N=2, mean ± range). (Image 
Courtesy Josh Wollam). 
a 
c 
e 
b 
d 
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Figure B.6. Rescue Experiments with Fractionated daf-22 Nematode Lipid 
Extracts. (A) Fractionated lipid extracts from daf-22(m130) rescue the Daf-c 
phenotypes of daf-9(dh6) mutants at 20°C. The fraction number reflects 
increasing polarity of the elution gradient, with an estimated 150 ng/μL sterol 
concentration per fraction. The control ∆7-dafachronic acid, as well as several 
fractions (Region 2: 24-25, Region 3: 27-28, Region 4: 37-39) rescue the 
animals to various extents (green arrows). This is a similar pattern of rescue 
as by wild-type extracts, but with increased efficacy, corresponding with 
increased DA levels found in daf-22 mutants (N=3, mean ± SD). (B) The same 
fractions also rescue daf-40(hd100) Daf-c phenotypes at 27°C, as well as 
fractions 14-19 (Region 1) which contain cholesterol and other proposed DA 
precursors (labeled with a blue line) (N=3, mean ± SD). (Image Courtesy: Josh 
Wollam).  
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Figure B.7. daf-40 Mutants are Less Responsive to DA Supplementation. 
(A) Dose response experiments with the recently identified ∆1,7-dafachronic 
acid show a similar trend to ∆7-dafachronic acid, as increased concentrations 
are required to rescue daf-40(hd100) dauer formation at 27°C compared to 
daf-9(dh6) mutants. (B) daf-40 mutants displayed a similarly reduced response 
of upon ∆4-dafachronic acid. (C) Although the newly identified 3α-hydroxy-∆7-
dafachronic acid shows slightly reduced ability to rescue daf-9 and daf-40 
dauer formation, daf-9;daf-40 double mutants show a dramatically reduced 
response. (D) qPCR analysis of the DAF-12 target gene mir-241 reveals that 
supplementation with high concentrations of ∆7-DA or 3α-hydroxy-∆7-DA 
rescues reduced expression seen in the daf-36 and daf-40 mutant 
backgrounds (100 nM, N≥4, mean ± SD, *P<0.01, **P<0.001, ***P<0.0001). 
(Image Courtesy Josh Wollam).  
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Figure B.8. Rescue Experiments with Fractionated Nematode Lipid 
Extracts Identify daf-9 Dependent Dafachronic Acid Activities. (A) 
Chromatographic separations of lipid extracts from wild-type (WT) animals 
were fed to daf-9(dh6) null mutants and animals were analyzed for rescue of 
Daf-c phenotypes at 20°C. The fraction number reflects increasing polarity of 
7-dafachronic acid, as well as several fractions (Region 
2: 25-26, Region 3: 28-29, Region 4: 38-39) rescue the animals to various 
extents (green arrows) (N=2 ± range). (B) The same wild-type fractions also 
rescue daf-40(hd100) Daf-c phenotypes at 27°C, as well as fractions 14-19 
(Region 1) which contain cholesterol and other proposed DA precursors 
(labeled with a blue line) (N=2 ± range). (C) daf-9(dh6) mutants are not 
rescued by fractions from daf-9(dh6);daf-12(rh61rh411), suggesting the wild-
type activities are daf-9 dependent DAF-12 ligands (N=2 ± range). (D) Earlier 
fractions from daf-9;daf-12 mutants still rescue daf-40 mutants (blue line), 
suggesting those activities are not daf-9 dependent, consistent with the 
presence of cholesterol metabolite DA precursors (N=2 ± range). (Image 
Courtesy Josh Wollam). 
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APPENDIX C 
 
1. C. elegans Strains and Maintenance 
Nematode stocks were maintained on Nematode Growth Medium (NGM) 
plates made with Bacto agar (BD Biosciences) and seeded with bacteria (E. 
coli strain OP50) at 20 °C (http://www.wormbook.org/). The following C. 
elegans strains were used: wild type (N2, Bristol), glo-1(zu437), flu-1(e1002), 
flu-2(1003), flu-3(e1001), flu-4(1004), nkat-1(ok566). Worms were grown at 20 
°C for at least two generations under replete growth conditions prior to growing 
in liquid cultures.  
 
2. Liquid Cultures 
Worms from four 10 cm NGM agar plates were washed using M9-medium into 
a 100 mL S-complete medium pre-culture where they were grown for four days 
at 22 °C on a rotary shaker. Concentrated bacteria derived from 1 L of E. coli 
OP50 culture was added as food at days one and three. Subsequently, the 
pre-culture was divided equally into sixteen 500 mL Erlenmeyer flask 
containing 100 mL of S-complete medium on day 4, which was then grown for 
an additional 5 days at 22 °C on a rotary shaker and fed with concentrated 
bacteria ad lib. The cultures were harvested on day 5 and centrifuged to 
separate the supernatant media and worm pellets. At harvest, liquid cultures 
contained approximately 80% L1-L3 worms. The worm pellets were stored at -
20 °C until used for further analyses. 
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3. C. elegans Stress and Killing Assays, RNAi and Supplementation 
experiments 
These experiments were carried out by Cassandra Coburn and other 
colleagues at David Gems’ Lab, University College London.   
 
Hyperoxia treatment. Young N2 adults were placed in either 90% O2 or air at 
25uC for 5 d on 10 mM FUdR (fluorodeoxyuridine), OP50 seeded NGM plates.  
 
Iron treatment. 15 mM ferric ammonium citrate (FAC) plates were prepared as 
previously described (Valentini et al., 2011). Young N2 adults were placed on 
fresh NGM or FAC plates for 24 h prior to fluorescence and carbonyl 
measurements. 
 
Worms were killed in three ways, detailed below, all of which result in bursts of 
blue fluorescence of similar magnitude. Heat killing was used to observe DF 
dynamics in individual animals in situ on NGM plates. This approach allows 
lethal stress to be applied near the head or tail, and allows observation of 
spatial changes in fluorescence, but is relatively difficult to quantitate. Killing by 
oxidative stress was used for higher resolution microscopy for which it was 
necessary to view worms under cover slips. Freeze-thaw assays of worms in 
microtitre plates were used for accurate quantitation of DF to compare 
genotypes cohorts of worms, and for acquisition of whole spectrum 
excitation/emission scans.  
 
Heat killing. Here fluorescence of individual animals was measured in situ on 
NGM plates after killing with a heated worm pick, fitted with a platinum wire 
(0.3 mm diameter). The wire was flame heated immediately prior to use, and 
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then placed briefly (~1 s) on the agar immediately adjacent to the worm (~0.1– 
0.2 mm away), and usually near the head end.  
 
Exposure to tert-butylhydroperoxide. Worms were exposed to 0.726 M (or 7%) 
t-BOOH, diluted in M9, for 5 min. Following exposure, worms were moved to a 
2% agarose pad for time-lapse imaging. Worms were imaged at 100X 
magnification, on a Nikon Eclipse TE2000-U inverted fluorescence microscope 
equipped with an excitation monochromator (Polychrome IV, TILL Photonics) 
and a high-speed monochromatic camera (Sensi-Cam, Cooke). Fluorescence 
emissions were monitored at 460 nm after 4 ms excitation at 360 nm. Images 
were captured every 10 s. Image capture and quantitative measurements were 
performed using the TILLvisION software package (TILL Photonics). Traces 
were plotted in Microsoft Excel. 
 
Freeze-thaw. Approximately 45 or 50 1-d adults worms per placed per 
condition in 150 mL M9 plus 0.2% levamisole in a V-shaped 96-well plate 
(Greiner Bio-One, Frickenhausen, Germany). The plate was then centrifuged 
at 1,500 rpm for 1 min and frozen at 280 °C for 15 min. The plate was then 
incubated at 42 °C in an Infinite 200 PRO plate-reader running Magellan 
software (Tecan Group Ltd., Switzerland) and blue fluorescence 
measurements were acquired every 30 s for 30 min and for each well, using 
λex/ λem 340±9/435±20 nm. A peak in fluorescence intensity occurred at, 7–10 
min marking the release of gut granule AA into the cytosol, and giving a 
readout of total AA fluorescence. Relative AA fluorescence was calculated as 
the difference between the initial minimum and subsequent peak fluorescence 
intensities for each well, normalized to the N2 control. To account for variation 
in worm size between conditions (genetic background or RNAi treatment), 
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relative AA fluorescence was then divided by a size factor. This size factor was 
obtained by imaging 30 worms by DIC microscopy at 106for each condition, 
measuring intestinal cross-sectional area and normalizing it to the control (N2) 
intestinal cross-sectional area.  
 
RNAi. The flu-2, kmo-1, nkat-1, and tdo-2 clones were acquired from the 
Ahringer library, and the inserts confirmed by DNA sequencing. E. coli HT115 
were transformed with the clone and fed to animals as described (Kamath RS, 
Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J (2001) Effectiveness 
of specific RNA-mediated interference through ingested doublestranded RNA 
in Caenorhabditis elegans. Genome Biol 2: RESEARCH0002). 
 
Anthranilic Acid Supplementation. A 55 mM stock of anthranilic acid (Sigma) 
was prepared by dissolving AA solid in PBS at 55 °C and then diluted further in 
PBS. Worms were incubated in AA solution for 3 h at 20 °C in a 96-well 
microtitre plate with constant shaking.  
 
4. Measurement of DF by Fluorescence spectroscopy and 
Microfluorimetry 
These experiments were carried out by Cassandra Coburn and other 
members of the David Gems’ Lab at UCL) and Filip Matthijssens (Bart P. 
Braeckman Lab, University of Ghent). 
Worms were either imaged in situ on NGM plates or anaesthetized on agar 
pads on glass slides. Images were acquired using an Orca digital camera 
(Hamamatsu) and a Leica DMRXA2 microscope. Blue fluorescence was 
observed through a DAPI filter cube (λex/λem 300–400 nm/410–510 nm) (ET 
DAPI, set 49000, Chroma). Green fluorescent protein (GFP) fluorescence was 
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observed through a GFP filter, (λex/λem 450–490 nm/500–550 nm) (Endow 
GFP Bandpass, 41017 Chroma). Images were acquired using the application 
Volocity Acquisition (Improvision, Perkin-Elmer). Fluorescence was quantified 
by manually tracing around worm peripheries using an Intuos graphics tablet 
(Wacom), and measuring mean pixel density using Volocity Quantitation. 
Worm fluorescence was estimated as the mean pixel density of the worm 
image area minus the pixel density of the image background. 
 
Time-lapse photography. Wild-type (N2) L4 hermaphrodites were cultured 
individually (one per plate) on NGM agar plates with E. coli OP50 and 10 mM 
FUdR (Gandhi et al., 1980). Worms were individually photographed in situ on 
the plates every 1–2 d until death and beyond as described below. Nematodes 
were placed on ice for 10 min prior to photography to induce stillness. 
Nematode viability phenotype was scored daily as described (Herndon et al., 
2002). 
 
Single-animal vermiculture. This was performed as previously described 
(Pincus et al., 2011). Fluorescence was measured under both DAPI and GFP 
filters, as before, and under a TRITC filter (λex/λem 530–560 nm/585–645 nm, 
TRITC 41002b, Chroma) 
 
Whole-Spectrum Excitation Emission Scans. Synchronous populations of L4 
animals were transferred to NGM plates seeded with E. coli OP50 and 
containing 50 mM FUdR (24uC). One-day-old adults were then rinsed off the 
plates and washed using S buffer. For each strain, three replicate aliquots of 
100 ml worm suspensions were loaded in black microtiter plates (Greiner). 
Aliquots resulted in ,1 mg alkali-extracted protein, determined by standard 
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BCA assay (ThermoScientific). The 10-nm step fluorescence emission spectra 
of living worm suspensions were measured upon excitation at 250–450 nm (10 
nm intervals) using a microplate reader (Spectramax Gemini XS, Molecular 
Devices). Worms were then killed by freeze-thaw and fluorescence 
measurements repeated. All data shown are averages of three technical 
replicates, corrected by a blank measurement, and normalized by protein 
content of the worm suspensions. 
 
5. Preparation of Metabolome Extracts 
 
Whole worm sonicates were prepared in dH2O from large heterogeneous 
populations grown on NGM plates. Sonication was performed in repeated 
cycles of 1 min followed by a 30 s pause for cooling in a ‘‘Bioruptor’’ water bath 
sonicator (Diagenode) until samples were homogenously clouded. Samples 
were spun down at 4 °C at 14,000 rpm for 15 min, and the supernatant 
extracted. Cold 100% ethanol was added in 1:9 sample: ethanol ratio and left 
at 220uC overnight. Samples were spun down again as above. The remaining 
supernatant was taken. Samples were then evaporated in vacuum at room 
temperature. For NMR-spectroscopic analysis, the residues were dissolved in 
200–600 mL of methanol-d4. Following NMR-spectroscopic analysis, samples 
were evaporated to dryness, resuspended in 500 mL methanol, centrifuged, 
and 1–30 mL aliquots were used for HPLC/MS analysis.  
 
6. Analytical Instrumentation and Procedures 
 
NMR spectroscopy: NMR spectra were recorded on a Varian INOVA 600 NMR 
(600 MHz for 1H, 151 MHz for 13C) and INOVA 400 NMR (400 MHz for 1H, 100 
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MHz for 13C) instruments. Non-gradient phase-cycled dqfCOSY spectra were 
acquired using the following parameters: 0.6 s acquisition time, 500-900 
complex increments, 8-32 scans per increment. Gradient and non-gradient 
HSQC[AD], HMQC, and HMBC[AD] spectra were acquired with these 
parameters: 0.25 s acquisition time, 300-600 increments, 8-32 scans per 
increment. 1H,13C-HMBC spectra were optimized for JH,C = 6 Hz. Susceptibility-
matched NMR tubes (Shigemi) were used for sample amounts smaller than 2 
mg. NMR spectra were processed using Varian VNMR, MestreLabs, 
MestReC, and Mnova software packages.  
 
HPLC-MS: HPLC-MS was performed using an Agilent 1100 Series HPLC 
system equipped with a Varian Pursuit XRs-3-C18 column (4.6 x 250 mm, 5 
µm particle diameter) connected to a Quattro II spectrometer 
(Micromass/Waters) A water (containing 0.1% acetic acid) – acetonitrile (also 
containing 0.1% acetic acid) solvent gradient was used at a flow rate of 0.7 
ml/min, starting with an acetonitrile content of 5% for 15 min which was 
increased to 35% over a period of 20 min and subsequently to 95% over a 
period of 5 min and continued at 95% for 6 min. Metabolite extracts were 
analyzed by positive and negative electrospray ionization-MS. High resolution 
HPLC-MS was performed using a Waters nanoACQUITY UPLC System 
equipped with a Waters Acquity UPLC HSS C-18 column (2.1 x 100 mm, 1.8 
µm particle diameter) connected to a Xevo G2 QTof Mass Spectrometer.  
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7. Synthesis of angl#1 (β-D-glucosyl anthranilic acid ester) 
 
 
Adapting a previously described procedure (Roell et al., 2011), a catalytic 
amount (about 1 mg, 0.025 mmol) of sodium hydroxide was added to a 
solution of 75 mg (0.462 mmol) of isatoic anhydride (Sigma-Aldrich, I12808) 
and 250 mg (0.462 mmol) of 2,3,4,6-tetra-O-benzyl-D-glucopyranose (Sigma-
Aldrich, 86730) in 4 mL dioxane. The reaction mixture was stirred and heated 
gradually until moderate evolution of CO2 occurred (75-90 °C). This 
temperature was maintained until gas evolution ceased (2 h) and the mixture 
was cooled and diluted with 6 ml of water. Crude 2,3,4,6-tetra-O-benzyl-D-
glucosyl anthranilic acid ester, containing both the α and β isomers, separated 
out as an immiscible oil and was extracted with methylene chloride (yield 255 
mg, 84%). To deprotect the glucose moiety, this mixture of products was 
dissolved in ethyl acetate (10 mL) to which 10 % palladium on activated 
carbon (28 mg) was added, and the resulting suspension was stirred under a 
hydrogen atmosphere for 24 h. Subsequently, the reaction vessel was flushed 
with argon, and the reaction mixture was filtered over Celite and the filtrate 
evaporated to dryness in vacuo.  An 10-mg sample of pure angl#1 was 
isolated from the mixture of α- and β-isomers by silica gel column 
chromatography using 20% ethyl acetate and hexane.  
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A sample of iglu#1 was synthesized as described previously (Messaoudi et al., 
2004).  
 
8. Compound names  
All newly identified C. elegans metabolites were named using their four letter 
"SMID"s (Small Molecule IDentifiers), e.g. "iglu#2" or "angl#1". The SMID 
database (www.smid-db.org) is an electronic resource maintained by Frank 
Schroeder and Lukas Mueller at the Boyce Thompson Institute in collaboration 
with Paul Sternberg and WormBase (www.wormbase.org). This database 
catalogues C. elegans small molecules, assigns a unique four-letter SMID, 
and for each compound lists other names and abbreviations used in the 
literature. 
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Figure C.1. DF is induced by different methods of killing and seen in 
other nematodes. (A) DF induced by hot pick killing in young WT adult, L4 
and male C. elegans as well as in other nematodes species C. briggsae and 
P. pacificus. (B) Typical fluorescence increase in young adult worm killed by a 
hot pick (C) Fluorescence increases in an anterior to posterior wave and DF 
will not propagate on the other way. (Image Courtesy: Cassandra Coburn)  
  
B A 
c 
a b 
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Figure C.2. Blue fluorescence is unlikely to be proteinaceous. (A) 
Fluorescence can be isolated to the supernatant of a homogenate and 
remains even after removal of protein (B). Data is mean of three (A) or two (B) 
biological replicates, error bars ± SD. (Image courtesy: Cassandra Coburn) 
  
a b 
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Figure C.3. Extracts from glo-1 animals do not contain fluorescent 
molecules at 340/430. HPLC chromatogram reveals four peaks present in N2 
but not in glo-1 animals 
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Figure C.4. Metabolite extracts from N2 worms show blue fluorescence.  
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Figure C.5. Proton NMR spectra of metabolite fractions show anthranilic 
acid moieties. Metabolite extracts from N2 worms showing blue fluorescence 
contain aromatic peaks corresponding to anthranilic acid moieties (blue 
boxes). Non-fluorescent fractions in the similar polarity range contain 
glucosylated indole compounds.  
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Figure C.6. Anthranilic acid supplementation rescues gut granule 
fluorescence and DF. (A) Effect on gut granule fluorescence of incubation in 
a range of AA concentrations. 5 mM AA gives fluorescence levels similar to 
wild type, (B) Epifluorescence microscopy reveals restoration of gut granule 
fluorescence by incubation in 5 mM AA (C) Effects of tdo-2(RNAi) and AA 
supplementation on peak DF (D) Similar kinetics of DF in control worms and 
tdo-2(RNAi) worms with AA-replenished gut granules, even though only the 
former can synthesize AA. image courtesy : Cassandra Coburn.  
  
a b 
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Figure C.7. NMR-based comparative metabolomics (DANS) applied to C. 
elegans wild type (N2) and flu-3. Comparison of the aromatic regions of 
dqfCOSY 2D NMR spectra of wild type (N2, upper panel) and flu-3 (lower 
panel) sonicates reveals that a specific kind of anthranilic acid moiety (black 
boxes) are absent in flu-3 mutants. Other anthranilic acid derivative cross 
peaks (red boxes) are unchanged or in some cases down regulated. Several 
other cross peaks remain unchanged (blue boxes). 
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Figure C.8. NMR-based comparative metabolomics (DANS) applied to C. 
elegans wild type (N2) and flu-4. Comparison of the aromatic regions of 
dqfCOSY 2D NMR spectra of wild type (N2, upper panel) and flu-4 (lower 
panel) sonicates reveals several groups of signals that are either strongly 
downregulated in the flu-4 spectrum (black boxes), or upregulated in the flu-
4(red boxes) or remain unchanged (blue boxes).  
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Table C.1. 1H (600 MHz), 13C (151 MHz), and HMBC NMR spectroscopic data 
for angl #1 in methanol-d4. Chemical shifts were referenced to (CD2HOD) = 
3.31 ppm and (CD2HOD) = 49.05 ppm.  
 
Position 
angl#1 
δ 13C 
[ppm] 
angl#1 
δ 1H 
[ppm] 
angl#21 
δ 1H [ppm] 
angl#1 
coupling  
constants 
[Hz] 
angl#1 
HMBC 
correlations 
1 95.2 5.70 5.77 J1,2’’ = 7.8 C-2, C-3, C-4, 
C-5, C-1’-COO 
2 73.8 3.50 3.67  C-1, C-3 
3 77.8 3.47 4.11 (JH,P = 8Hz)  C-2, C-4 
4 70.8 3.40 3.59  C-5 
5 78.5 3.44   C-1, C-4 
6a 62.1 3.86  J6a,6b = 12.1,  
J5,6a = 5.2 
C-4, C-5 
6b  3.70  J5,6b = 2.1 C-4, C-5 
1’-COO 167.8     
1′ 109.8     
2′ 153.1     
3′ 117.5 6.75  J3,4 = 8.5, 
J3,5 = 1.1 
C-1’, C-5’, C-1’-
COO 
4′ 135.5 7.26  J4,5 = 7.1, 
J4,6 = 1.7 
C-2’, C-6’ 
5′ 116.1 6.57  J5,6 = 8.2  C-1’, C-3’ 
6′ 132.1 7.89   C-2’, C-4’, C-1’-
COO 
1Characteristic 1H NMR signals of angl#2.  
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Table C.2.  1H (600 MHz), 13C (151 MHz), and HMBC NMR spectroscopic 
data for iglu #1 in methanol-d4. Chemical shifts were referenced to (CD2HOD) 
= 3.31 ppm and (CD2HOD) = 49.05 ppm.  
 
Position iglu#1 
δ 
13
C 
[ppm] 
iglu#1 
δ
1
H 
[ppm] 
iglu#2
1
 
δ 
1
H [ppm]
 
iglu#1 
1
H-
1
H-
coupling  
constants [Hz] 
iglu#1 HMBC 
correlations 
1 86.5 5.46 5.55 J1,2 = 9.0 C-2, C-3, C-5, 
C-2’, C-7a’ 
2 73.4 3.94 4.12 J2,3 = 9.0, C-1, C-3 
3 78.9 3.60 4.24(JH,P = 8Hz) J3,4 = 9.0 C-2, C-4 
4 71.2 3.50 3.68 J4,5 = 9.0 C-3, C-5, C-6 
5 80.4 3.58  J5,6a = 5.8 C-1, C-3, C-6 
6a 62.5 3.70  J6a,6b = 12.1 C-4, C-5 
6b  3.88  J5,6b = 2.2 C-4, C-5 
2′ 126.2 7.40  J2’,3’ = 3.3 C-1(weak), C-3', 
C-3a’, C-
7’(weak), C-7a’  
3′ 103.2 6.49   C-2’, C-3a’, C-4’ 
(weak), C-7a’ 
(weak) 
3a′ 130.3     
4′ 121.3 7.52  J4’,5’ = 8.0,  C-3’, C-6’, C-7a’ 
5′ 120.7 7.05  J5’,6’ = 7.4, J3,5 = 1.1, C-3a’, C-7’ 
6′ 122.4 7.15  J6’,7’ = 8.0, J4’,6’ = 1.0 C-4’, C-7a’ 
7′ 111.2 7.54   C-3a’, C-5’ 
7a′ 137.8     
1Characteristic 1H NMR signals of iglu#2.  
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Table C.3. High-resolution MS data for previously unreported C. elegans 
metabolites angl#1, angl#2, iglu#1, and iglu#2, acquired using negative-ion 
electrospray ionization (ESI-).  
 
Compound Ion Ion formula 
Calculated 
m/z 
Observed 
m/z 
angl#1 [M-H]- C13H16NO7
- 298.0932 298.0910 
angl#2 [M-H]- C13H17NO10P
- 378.0596 378.0600 
iglu#1 [M-H]- C14H16NO5
- 278.1034 278.1071 
iglu#2 [M-H]- C14H17NO8P
- 358.0697 358.0701 
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NMR Spectra of angl#1 
1
H NMR Spectrum (600 MHz, CD3OD) of ang#1 
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dqfCOSY Spectrum (600 MHz, CD3OD) of ang#1 
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HMBC Spectrum (600 MHz for 
1
H, 151 MHz for 
13
C, CD3OD) of ang#1 
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HMQC Spectrum (600 MHz for 
1
H, 151 MHz for 
13
C, CD3OD) of ang#1 
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